Sentence	entity_1	entity_2	entity_3	entity_4	entity_5	entity_6	entity_7	entity_8	json	split
To elucidate the role of N - glycosylation in the functional activity of the universal glucose transporter, Glut - 1, we investigated effects of the N - glycosylation inhibitor, tunicamycin, on glucose transport by human leukemic cell lines K562, U937 and HL60.	glucose,87,94,Chemical	Glut - 1,108,116,Gene_or_gene_product	tunicamycin,178,189,Chemical	glucose,194,201,Chemical	human,215,220,Organism	leukemic cell lines K562,221,245,Cell	U937,247,251,Cell	HL60,256,260,Cell	"[{""token"": ""glucose"", ""start_span"": 87, ""end_span"": 94, ""type"": ""Chemical""}, {""token"": ""Glut - 1"", ""start_span"": 108, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""tunicamycin"", ""start_span"": 178, ""end_span"": 189, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 194, ""end_span"": 201, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 215, ""end_span"": 220, ""type"": ""Organism""}, {""token"": ""leukemic cell lines K562"", ""start_span"": 221, ""end_span"": 245, ""type"": ""Cell""}, {""token"": ""U937"", ""start_span"": 247, ""end_span"": 251, ""type"": ""Cell""}, {""token"": ""HL60"", ""start_span"": 256, ""end_span"": 260, ""type"": ""Cell""}]"	train
Since AP - 1 and NF - kappa B are key elements in controlling interleukin - 8 ( IL - 8) transcription, human fibroblasts were treated with alpha - MSH and IL - 1 beta for 24 hours, and cytokine levels in the supernatants were measured by ELISA.	AP - 1,6,12,Gene_or_gene_product	NF - kappa B,17,29,Gene_or_gene_product	interleukin - 8,62,77,Gene_or_gene_product	IL - 8,80,86,Gene_or_gene_product	human,103,108,Organism	fibroblasts,109,120,Cell	alpha - MSH,139,150,Gene_or_gene_product	IL - 1 beta,155,166,Gene_or_gene_product	"[{""token"": ""AP - 1"", ""start_span"": 6, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappa B"", ""start_span"": 17, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""interleukin - 8"", ""start_span"": 62, ""end_span"": 77, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 8"", ""start_span"": 80, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Organism""}, {""token"": ""fibroblasts"", ""start_span"": 109, ""end_span"": 120, ""type"": ""Cell""}, {""token"": ""alpha - MSH"", ""start_span"": 139, ""end_span"": 150, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 1 beta"", ""start_span"": 155, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}]"	train
Here we show that IL - 12 activates an anti - angiogenic program in Con A - activated mouse spleen cells ( activated spc) or human PBMC ( activated PBMC).	IL - 12,18,25,Gene_or_gene_product	Con A,68,73,Chemical	mouse,86,91,Organism	spleen cells,92,104,Cell	spc,117,120,Cell	human,125,130,Organism	PBMC,131,135,Cell	PBMC,148,152,Cell	"[{""token"": ""IL - 12"", ""start_span"": 18, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""Con A"", ""start_span"": 68, ""end_span"": 73, ""type"": ""Chemical""}, {""token"": ""mouse"", ""start_span"": 86, ""end_span"": 91, ""type"": ""Organism""}, {""token"": ""spleen cells"", ""start_span"": 92, ""end_span"": 104, ""type"": ""Cell""}, {""token"": ""spc"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 125, ""end_span"": 130, ""type"": ""Organism""}, {""token"": ""PBMC"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Cell""}, {""token"": ""PBMC"", ""start_span"": 148, ""end_span"": 152, ""type"": ""Cell""}]"	train
Experiments with nu / nu mice, nonobese diabetic - SCID mice, or activated spc enriched in specific cell subpopulations demonstrated that CD4 ( +), CD8 ( +), and NK cells are all needed to mediate the full anti - angiogenetic effect of IL - 12.	nu / nu mice,17,29,Organism	nonobese diabetic - SCID mice,31,60,Organism	spc,75,78,Cell	cell,100,104,Cell	CD4,138,141,Gene_or_gene_product	CD8,148,151,Gene_or_gene_product	NK cells,162,170,Cell	IL - 12,236,243,Gene_or_gene_product	"[{""token"": ""nu / nu mice"", ""start_span"": 17, ""end_span"": 29, ""type"": ""Organism""}, {""token"": ""nonobese diabetic - SCID mice"", ""start_span"": 31, ""end_span"": 60, ""type"": ""Organism""}, {""token"": ""spc"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Cell""}, {""token"": ""CD4"", ""start_span"": 138, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD8"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}, {""token"": ""NK cells"", ""start_span"": 162, ""end_span"": 170, ""type"": ""Cell""}, {""token"": ""IL - 12"", ""start_span"": 236, ""end_span"": 243, ""type"": ""Gene_or_gene_product""}]"	train
To observe the influence of fungus polysaccharides compounds ( FPC) in inducing human liver cancer cell Bel - 7402 apoptosis in cell cultivating in vitro, the authors analyzed tumor inhibitive gene P53 expression in Bel - 7402 apoptosis by applying double immuno - marker.	fungus polysaccharides compounds,28,60,Chemical	FPC,63,66,Chemical	human,80,85,Organism	liver cancer cell Bel - 7402,86,114,Cell	cell,128,132,Cell	tumor,176,181,Cancer	P53,198,201,Gene_or_gene_product	Bel - 7402,216,226,Cell	"[{""token"": ""fungus polysaccharides compounds"", ""start_span"": 28, ""end_span"": 60, ""type"": ""Chemical""}, {""token"": ""FPC"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Organism""}, {""token"": ""liver cancer cell Bel - 7402"", ""start_span"": 86, ""end_span"": 114, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 176, ""end_span"": 181, ""type"": ""Cancer""}, {""token"": ""P53"", ""start_span"": 198, ""end_span"": 201, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bel - 7402"", ""start_span"": 216, ""end_span"": 226, ""type"": ""Cell""}]"	train
Twenty - one patients underwent resection of the remnant stomach for RSC and were divided into two groups: the RSCB group consisted of 11 patients who underwent distal gastrectomy for benign disease and the RSCM group consisted of 10 patients who underwent gastrectomy for primary gastric cancer.	patients,13,21,Organism	remnant stomach,49,64,Organ	RSC,69,72,Cancer	RSCB,111,115,Cancer	patients,138,146,Organism	RSCM,207,211,Cancer	patients,234,242,Organism	gastric cancer,281,295,Cancer	"[{""token"": ""patients"", ""start_span"": 13, ""end_span"": 21, ""type"": ""Organism""}, {""token"": ""remnant stomach"", ""start_span"": 49, ""end_span"": 64, ""type"": ""Organ""}, {""token"": ""RSC"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Cancer""}, {""token"": ""RSCB"", ""start_span"": 111, ""end_span"": 115, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 138, ""end_span"": 146, ""type"": ""Organism""}, {""token"": ""RSCM"", ""start_span"": 207, ""end_span"": 211, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 234, ""end_span"": 242, ""type"": ""Organism""}, {""token"": ""gastric cancer"", ""start_span"": 281, ""end_span"": 295, ""type"": ""Cancer""}]"	train
A specific histone deacetylase ( HDAc) inhibitor, trichostatin A ( TSA), alleviates Evi - 1 - mediated repression of TGF - beta signaling, suggesting that HDAc is involved in transcriptional repression by Evi - 1.	histone deacetylase,11,30,Gene_or_gene_product	HDAc,33,37,Gene_or_gene_product	trichostatin A,50,64,Chemical	TSA,67,70,Chemical	Evi - 1,84,91,Gene_or_gene_product	TGF - beta,117,127,Gene_or_gene_product	HDAc,155,159,Gene_or_gene_product	Evi - 1,205,212,Gene_or_gene_product	"[{""token"": ""histone deacetylase"", ""start_span"": 11, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""HDAc"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""trichostatin A"", ""start_span"": 50, ""end_span"": 64, ""type"": ""Chemical""}, {""token"": ""TSA"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Chemical""}, {""token"": ""Evi - 1"", ""start_span"": 84, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGF - beta"", ""start_span"": 117, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}, {""token"": ""HDAc"", ""start_span"": 155, ""end_span"": 159, ""type"": ""Gene_or_gene_product""}, {""token"": ""Evi - 1"", ""start_span"": 205, ""end_span"": 212, ""type"": ""Gene_or_gene_product""}]"	train
The non - invasive human melanoma cell line, IF6, which does not express uPA, provided further confirmation of PAI - 1 and uPA ' s role as, upon transfection with uPA, this cell line attained an invasive phenotype, which was again attenuated by MAI - 12.	human,19,24,Organism	melanoma cell line,25,43,Cell	IF6,45,48,Cell	uPA,73,76,Gene_or_gene_product	PAI - 1,111,118,Gene_or_gene_product	uPA,123,126,Gene_or_gene_product	uPA,163,166,Gene_or_gene_product	cell line,173,182,Cell	"[{""token"": ""human"", ""start_span"": 19, ""end_span"": 24, ""type"": ""Organism""}, {""token"": ""melanoma cell line"", ""start_span"": 25, ""end_span"": 43, ""type"": ""Cell""}, {""token"": ""IF6"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Cell""}, {""token"": ""uPA"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""PAI - 1"", ""start_span"": 111, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""uPA"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}, {""token"": ""uPA"", ""start_span"": 163, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell line"", ""start_span"": 173, ""end_span"": 182, ""type"": ""Cell""}]"	train
Since congenital neutropenia and SDS are inherited forms of bone marrow failure, G - CSF may accelerate the propensity for MDS / AML in the genetically altered stem and progenitor cells, especially in those with G - CSF receptor and ras mutations ( 82% and 50% of patients who transform, respectively).	bone marrow,60,71,Multi	G - CSF,81,88,Gene_or_gene_product	AML,129,132,Cancer	stem,160,164,Cell	progenitor cells,169,185,Cell	G - CSF receptor,212,228,Gene_or_gene_product	ras,233,236,Gene_or_gene_product	patients,264,272,Organism	"[{""token"": ""bone marrow"", ""start_span"": 60, ""end_span"": 71, ""type"": ""Multi""}, {""token"": ""G - CSF"", ""start_span"": 81, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""AML"", ""start_span"": 129, ""end_span"": 132, ""type"": ""Cancer""}, {""token"": ""stem"", ""start_span"": 160, ""end_span"": 164, ""type"": ""Cell""}, {""token"": ""progenitor cells"", ""start_span"": 169, ""end_span"": 185, ""type"": ""Cell""}, {""token"": ""G - CSF receptor"", ""start_span"": 212, ""end_span"": 228, ""type"": ""Gene_or_gene_product""}, {""token"": ""ras"", ""start_span"": 233, ""end_span"": 236, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 264, ""end_span"": 272, ""type"": ""Organism""}]"	train
Western blotting of p53 and murine double mutant 2 ( Mdm2) together with p53 DNA sequencing analysis indicate that p53 function loss by mutation or overexpression of Mdm2 occurred in all tested oral cancer cells regardless of their etiology.	p53,20,23,Gene_or_gene_product	murine double mutant 2,28,50,Gene_or_gene_product	Mdm2,53,57,Gene_or_gene_product	p53,73,76,Gene_or_gene_product	DNA,77,80,Cellular_component	p53,115,118,Gene_or_gene_product	Mdm2,166,170,Gene_or_gene_product	oral cancer cells,194,211,Cell	"[{""token"": ""p53"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""murine double mutant 2"", ""start_span"": 28, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""Mdm2"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Cellular_component""}, {""token"": ""p53"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""Mdm2"", ""start_span"": 166, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}, {""token"": ""oral cancer cells"", ""start_span"": 194, ""end_span"": 211, ""type"": ""Cell""}]"	train
The tumors of A431 supplemented with F - 2 cells were profoundly vascularized throughout by the tubular structures formed by F - 2 cells, the lumen of which contained the host rat blood cells.	tumors,4,10,Cancer	A431,14,18,Cell	F - 2 cells,37,48,Cell	tubular structures,96,114,Tissue	F - 2 cells,125,136,Cell	lumen,142,147,Immaterial_anatomical_entity	rat,176,179,Organism	blood cells,180,191,Cell	"[{""token"": ""tumors"", ""start_span"": 4, ""end_span"": 10, ""type"": ""Cancer""}, {""token"": ""A431"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Cell""}, {""token"": ""F - 2 cells"", ""start_span"": 37, ""end_span"": 48, ""type"": ""Cell""}, {""token"": ""tubular structures"", ""start_span"": 96, ""end_span"": 114, ""type"": ""Tissue""}, {""token"": ""F - 2 cells"", ""start_span"": 125, ""end_span"": 136, ""type"": ""Cell""}, {""token"": ""lumen"", ""start_span"": 142, ""end_span"": 147, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""rat"", ""start_span"": 176, ""end_span"": 179, ""type"": ""Organism""}, {""token"": ""blood cells"", ""start_span"": 180, ""end_span"": 191, ""type"": ""Cell""}]"	train
To investigate whether bee venom ( BV) induces apoptosis, the 3 - ( 4, 5 - dimethylthiazol - 2 - yl) - 2, 5 - diphenyltetrazolium bromide assay, terminal deoxynucleotidyl transferase - mediated dUTP nick end - labeling assay, 4, 6 - diamidino - 2 - phenylindole staining, flow cytometric analysis, and DNA fragmentation assay were performed on NCI - H1299 lung cancer cells treated with BV.	bee,23,26,Organism	venom,27,32,Organism_substance	BV,35,37,Organism_substance	terminal deoxynucleotidyl transferase,145,182,Gene_or_gene_product	dUTP,194,198,Chemical	DNA,302,305,Cellular_component	NCI - H1299 lung cancer cells,344,373,Cell	BV,387,389,Organism_substance	"[{""token"": ""bee"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Organism""}, {""token"": ""venom"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Organism_substance""}, {""token"": ""BV"", ""start_span"": 35, ""end_span"": 37, ""type"": ""Organism_substance""}, {""token"": ""terminal deoxynucleotidyl transferase"", ""start_span"": 145, ""end_span"": 182, ""type"": ""Gene_or_gene_product""}, {""token"": ""dUTP"", ""start_span"": 194, ""end_span"": 198, ""type"": ""Chemical""}, {""token"": ""DNA"", ""start_span"": 302, ""end_span"": 305, ""type"": ""Cellular_component""}, {""token"": ""NCI - H1299 lung cancer cells"", ""start_span"": 344, ""end_span"": 373, ""type"": ""Cell""}, {""token"": ""BV"", ""start_span"": 387, ""end_span"": 389, ""type"": ""Organism_substance""}]"	train
To determine whether changes in angiogenesis are responsible for the decrease in progesterone synthesis, we measured hemoglobin and CD34 levels in luteinized ovaries following injection of COX inhibitors and measured the relative frequency of cells positive for platelet - endothelial cell adhesion molecule as a specific marker for endothelial cells.	progesterone,81,93,Chemical	hemoglobin,117,127,Gene_or_gene_product	CD34,132,136,Gene_or_gene_product	ovaries,158,165,Organ	COX,189,192,Gene_or_gene_product	cells,243,248,Cell	platelet - endothelial cell adhesion molecule,262,307,Gene_or_gene_product	endothelial cells,333,350,Cell	"[{""token"": ""progesterone"", ""start_span"": 81, ""end_span"": 93, ""type"": ""Chemical""}, {""token"": ""hemoglobin"", ""start_span"": 117, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD34"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovaries"", ""start_span"": 158, ""end_span"": 165, ""type"": ""Organ""}, {""token"": ""COX"", ""start_span"": 189, ""end_span"": 192, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 243, ""end_span"": 248, ""type"": ""Cell""}, {""token"": ""platelet - endothelial cell adhesion molecule"", ""start_span"": 262, ""end_span"": 307, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 333, ""end_span"": 350, ""type"": ""Cell""}]"	train
Leukocyte - vessel wall interactions were studied both within and outside small tumors growing in the ear, and in ear microvessels of mice with a large tumor growing on their flank.	Leukocyte,0,9,Cell	vessel wall,12,23,Multi	tumors,80,86,Cancer	ear,102,105,Organ	ear microvessels,114,130,Tissue	mice,134,138,Organism	tumor,152,157,Cancer	flank,175,180,Organism_subdivision	"[{""token"": ""Leukocyte"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Cell""}, {""token"": ""vessel wall"", ""start_span"": 12, ""end_span"": 23, ""type"": ""Multi""}, {""token"": ""tumors"", ""start_span"": 80, ""end_span"": 86, ""type"": ""Cancer""}, {""token"": ""ear"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Organ""}, {""token"": ""ear microvessels"", ""start_span"": 114, ""end_span"": 130, ""type"": ""Tissue""}, {""token"": ""mice"", ""start_span"": 134, ""end_span"": 138, ""type"": ""Organism""}, {""token"": ""tumor"", ""start_span"": 152, ""end_span"": 157, ""type"": ""Cancer""}, {""token"": ""flank"", ""start_span"": 175, ""end_span"": 180, ""type"": ""Organism_subdivision""}]"	train
The cell death pathway initiated by survivin targeting was mapped with respect to cytochrome c release, changes in mitochondrial transmembrane potential, and apoptosome requirements using mouse embryonic fibroblasts deficient in Apaf - 1 or caspase - 9.	cell,4,8,Cell	survivin,36,44,Gene_or_gene_product	cytochrome c,82,94,Gene_or_gene_product	mitochondrial,115,128,Cellular_component	mouse,188,193,Organism	embryonic fibroblasts,194,215,Cell	Apaf - 1,229,237,Gene_or_gene_product	caspase - 9,241,252,Gene_or_gene_product	"[{""token"": ""cell"", ""start_span"": 4, ""end_span"": 8, ""type"": ""Cell""}, {""token"": ""survivin"", ""start_span"": 36, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""cytochrome c"", ""start_span"": 82, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitochondrial"", ""start_span"": 115, ""end_span"": 128, ""type"": ""Cellular_component""}, {""token"": ""mouse"", ""start_span"": 188, ""end_span"": 193, ""type"": ""Organism""}, {""token"": ""embryonic fibroblasts"", ""start_span"": 194, ""end_span"": 215, ""type"": ""Cell""}, {""token"": ""Apaf - 1"", ""start_span"": 229, ""end_span"": 237, ""type"": ""Gene_or_gene_product""}, {""token"": ""caspase - 9"", ""start_span"": 241, ""end_span"": 252, ""type"": ""Gene_or_gene_product""}]"	train
Granulocyte - macrophage colony - stimulating factor and interleukin - 3 enhance the incorporation of cytosine arabinoside into the DNA of leukemic blasts and the cytotoxic effect on clonogenic cells from patients with acute myeloid leukemia.	Granulocyte - macrophage colony - stimulating factor,0,52,Gene_or_gene_product	interleukin - 3,57,72,Gene_or_gene_product	cytosine arabinoside,102,122,Chemical	DNA,132,135,Cellular_component	leukemic blasts,139,154,Cell	clonogenic cells,183,199,Cell	patients,205,213,Organism	acute myeloid leukemia,219,241,Cancer	"[{""token"": ""Granulocyte - macrophage colony - stimulating factor"", ""start_span"": 0, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""interleukin - 3"", ""start_span"": 57, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""cytosine arabinoside"", ""start_span"": 102, ""end_span"": 122, ""type"": ""Chemical""}, {""token"": ""DNA"", ""start_span"": 132, ""end_span"": 135, ""type"": ""Cellular_component""}, {""token"": ""leukemic blasts"", ""start_span"": 139, ""end_span"": 154, ""type"": ""Cell""}, {""token"": ""clonogenic cells"", ""start_span"": 183, ""end_span"": 199, ""type"": ""Cell""}, {""token"": ""patients"", ""start_span"": 205, ""end_span"": 213, ""type"": ""Organism""}, {""token"": ""acute myeloid leukemia"", ""start_span"": 219, ""end_span"": 241, ""type"": ""Cancer""}]"	train
Here, the pattern of expression of angiogenin during the transition from normal breast tissue to ductal carcinoma in situ and invasive carcinoma is reported together with the correlates between the level of angiogenin in 239 invasive carcinomas and standard clinicopathological parameters, hypoxia - inducible factor ( HIF) - 1 alpha and the HIF - 1 alpha target gene DEC - 1.	angiogenin,35,45,Gene_or_gene_product	breast tissue,80,93,Tissue	ductal carcinoma,97,113,Cancer	carcinoma,135,144,Cancer	angiogenin,207,217,Gene_or_gene_product	carcinomas,234,244,Cancer	HIF - 1 alpha,342,355,Gene_or_gene_product	DEC - 1,368,375,Gene_or_gene_product	"[{""token"": ""angiogenin"", ""start_span"": 35, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast tissue"", ""start_span"": 80, ""end_span"": 93, ""type"": ""Tissue""}, {""token"": ""ductal carcinoma"", ""start_span"": 97, ""end_span"": 113, ""type"": ""Cancer""}, {""token"": ""carcinoma"", ""start_span"": 135, ""end_span"": 144, ""type"": ""Cancer""}, {""token"": ""angiogenin"", ""start_span"": 207, ""end_span"": 217, ""type"": ""Gene_or_gene_product""}, {""token"": ""carcinomas"", ""start_span"": 234, ""end_span"": 244, ""type"": ""Cancer""}, {""token"": ""HIF - 1 alpha"", ""start_span"": 342, ""end_span"": 355, ""type"": ""Gene_or_gene_product""}, {""token"": ""DEC - 1"", ""start_span"": 368, ""end_span"": 375, ""type"": ""Gene_or_gene_product""}]"	train
Mutations in the genes encoding the three other succinate dehydrogenase subunits ( SDHB, SDHC and SDHD) have been identified in patients affected by familial or ' apparently sporadic ' paraganglioma and / or pheochromocytoma, an autosomal inherited cancer - susceptibility syndrome.	succinate dehydrogenase,48,71,Gene_or_gene_product	SDHB,83,87,Gene_or_gene_product	SDHC,89,93,Gene_or_gene_product	SDHD,98,102,Gene_or_gene_product	patients,128,136,Organism	paraganglioma,185,198,Cancer	pheochromocytoma,208,224,Cancer	cancer,249,255,Cancer	"[{""token"": ""succinate dehydrogenase"", ""start_span"": 48, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""SDHB"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""SDHC"", ""start_span"": 89, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}, {""token"": ""SDHD"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 128, ""end_span"": 136, ""type"": ""Organism""}, {""token"": ""paraganglioma"", ""start_span"": 185, ""end_span"": 198, ""type"": ""Cancer""}, {""token"": ""pheochromocytoma"", ""start_span"": 208, ""end_span"": 224, ""type"": ""Cancer""}, {""token"": ""cancer"", ""start_span"": 249, ""end_span"": 255, ""type"": ""Cancer""}]"	train
The subsequent identification of germline mutations in the gene encoding fumarase - - another TCA cycle enzyme - - in a new hereditary form of susceptibility to renal, uterine and cutaneous tumors has highlighted the potential role of the TCA cycle and, more generally, of the mitochondria in cancer.	fumarase,73,81,Gene_or_gene_product	TCA,94,97,Chemical	renal,161,166,Cancer	uterine,168,175,Cancer	cutaneous tumors,180,196,Cancer	TCA,239,242,Chemical	mitochondria,277,289,Cellular_component	cancer,293,299,Cancer	"[{""token"": ""fumarase"", ""start_span"": 73, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""TCA"", ""start_span"": 94, ""end_span"": 97, ""type"": ""Chemical""}, {""token"": ""renal"", ""start_span"": 161, ""end_span"": 166, ""type"": ""Cancer""}, {""token"": ""uterine"", ""start_span"": 168, ""end_span"": 175, ""type"": ""Cancer""}, {""token"": ""cutaneous tumors"", ""start_span"": 180, ""end_span"": 196, ""type"": ""Cancer""}, {""token"": ""TCA"", ""start_span"": 239, ""end_span"": 242, ""type"": ""Chemical""}, {""token"": ""mitochondria"", ""start_span"": 277, ""end_span"": 289, ""type"": ""Cellular_component""}, {""token"": ""cancer"", ""start_span"": 293, ""end_span"": 299, ""type"": ""Cancer""}]"	train
Two of these cell cycle inhibitors, p16 ( INK4A) and p15 ( INK4B), have tumor suppressor activities and are inactivated in human cancer.	cell,13,17,Cell	p16,36,39,Gene_or_gene_product	INK4A,42,47,Gene_or_gene_product	p15,53,56,Gene_or_gene_product	INK4B,59,64,Gene_or_gene_product	tumor,72,77,Cancer	human,123,128,Organism	cancer,129,135,Cancer	"[{""token"": ""cell"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Cell""}, {""token"": ""p16"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""INK4A"", ""start_span"": 42, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""p15"", ""start_span"": 53, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""INK4B"", ""start_span"": 59, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 72, ""end_span"": 77, ""type"": ""Cancer""}, {""token"": ""human"", ""start_span"": 123, ""end_span"": 128, ""type"": ""Organism""}, {""token"": ""cancer"", ""start_span"": 129, ""end_span"": 135, ""type"": ""Cancer""}]"	train
We also show that mouse p10 is able to inhibit foci formation and anchorage - independent growth in wild - type mouse embryonic fibroblasts, and that these antitransforming properties of mouse p10 are also p53 - dependent.	mouse,18,23,Organism	p10,24,27,Gene_or_gene_product	foci,47,51,Cell	mouse,112,117,Organism	embryonic fibroblasts,118,139,Cell	mouse,187,192,Organism	p10,193,196,Gene_or_gene_product	p53,206,209,Gene_or_gene_product	"[{""token"": ""mouse"", ""start_span"": 18, ""end_span"": 23, ""type"": ""Organism""}, {""token"": ""p10"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""foci"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Cell""}, {""token"": ""mouse"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Organism""}, {""token"": ""embryonic fibroblasts"", ""start_span"": 118, ""end_span"": 139, ""type"": ""Cell""}, {""token"": ""mouse"", ""start_span"": 187, ""end_span"": 192, ""type"": ""Organism""}, {""token"": ""p10"", ""start_span"": 193, ""end_span"": 196, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 206, ""end_span"": 209, ""type"": ""Gene_or_gene_product""}]"	train
This study examines the mechanism of HKa and D5 inhibition of two potent stimulators of endothelial cell migration, sphingosine 1 - phosphate ( S1P) and vascular endothelial growth factor ( VEGF), that act through the P13 - kinase - Akt signaling pathway.	HKa,37,40,Gene_or_gene_product	endothelial cell,88,104,Cell	sphingosine 1 - phosphate,116,141,Gene_or_gene_product	S1P,144,147,Gene_or_gene_product	vascular endothelial growth factor,153,187,Gene_or_gene_product	VEGF,190,194,Gene_or_gene_product	P13 - kinase,218,230,Gene_or_gene_product	Akt,233,236,Gene_or_gene_product	"[{""token"": ""HKa"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 88, ""end_span"": 104, ""type"": ""Cell""}, {""token"": ""sphingosine 1 - phosphate"", ""start_span"": 116, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}, {""token"": ""S1P"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 153, ""end_span"": 187, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 190, ""end_span"": 194, ""type"": ""Gene_or_gene_product""}, {""token"": ""P13 - kinase"", ""start_span"": 218, ""end_span"": 230, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 233, ""end_span"": 236, ""type"": ""Gene_or_gene_product""}]"	train
Inhibitors of Akt and P13 - kinase, the upstream activator of Akt, block endothelial cell migration and disrupt paxillin localization to the focal adhesions after stimulation with VEGF and S1P.	Akt,14,17,Gene_or_gene_product	P13 - kinase,22,34,Gene_or_gene_product	Akt,62,65,Gene_or_gene_product	endothelial cell,73,89,Cell	paxillin,112,120,Gene_or_gene_product	focal adhesions,141,156,Cellular_component	VEGF,180,184,Gene_or_gene_product	S1P,189,192,Gene_or_gene_product	"[{""token"": ""Akt"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""P13 - kinase"", ""start_span"": 22, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cell"", ""start_span"": 73, ""end_span"": 89, ""type"": ""Cell""}, {""token"": ""paxillin"", ""start_span"": 112, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""focal adhesions"", ""start_span"": 141, ""end_span"": 156, ""type"": ""Cellular_component""}, {""token"": ""VEGF"", ""start_span"": 180, ""end_span"": 184, ""type"": ""Gene_or_gene_product""}, {""token"": ""S1P"", ""start_span"": 189, ""end_span"": 192, ""type"": ""Gene_or_gene_product""}]"	train
In this study, we used two inflammatory agents, IL - 1beta and phorbol myristic acetate, to activate PKC isozymes and specific inhibitors of PKCalpha ( Go6976) and PKCbeta ( hispidin) to distinguish how each of these isoform ( s) controls angiogenesis, wound healing, and permeability.	IL - 1beta,48,58,Gene_or_gene_product	phorbol myristic acetate,63,87,Chemical	PKC,101,104,Gene_or_gene_product	PKCalpha,141,149,Gene_or_gene_product	Go6976,152,158,Chemical	PKCbeta,164,171,Gene_or_gene_product	hispidin,174,182,Chemical	wound,253,258,Pathological_formation	"[{""token"": ""IL - 1beta"", ""start_span"": 48, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""phorbol myristic acetate"", ""start_span"": 63, ""end_span"": 87, ""type"": ""Chemical""}, {""token"": ""PKC"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""PKCalpha"", ""start_span"": 141, ""end_span"": 149, ""type"": ""Gene_or_gene_product""}, {""token"": ""Go6976"", ""start_span"": 152, ""end_span"": 158, ""type"": ""Chemical""}, {""token"": ""PKCbeta"", ""start_span"": 164, ""end_span"": 171, ""type"": ""Gene_or_gene_product""}, {""token"": ""hispidin"", ""start_span"": 174, ""end_span"": 182, ""type"": ""Chemical""}, {""token"": ""wound"", ""start_span"": 253, ""end_span"": 258, ""type"": ""Pathological_formation""}]"	train
We show that LRP - 1 deficiency in murine embryonic fibroblasts ( MEFs) is associated with increased levels of type III collagen and pigment epithelium - derived factor, which accumulate in the substratum surrounding cells.	LRP - 1,13,20,Gene_or_gene_product	murine,35,41,Organism	embryonic fibroblasts,42,63,Cell	MEFs,66,70,Cell	type III collagen,111,128,Gene_or_gene_product	pigment epithelium - derived factor,133,168,Gene_or_gene_product	substratum,194,204,Cellular_component	cells,217,222,Cell	"[{""token"": ""LRP - 1"", ""start_span"": 13, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""murine"", ""start_span"": 35, ""end_span"": 41, ""type"": ""Organism""}, {""token"": ""embryonic fibroblasts"", ""start_span"": 42, ""end_span"": 63, ""type"": ""Cell""}, {""token"": ""MEFs"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Cell""}, {""token"": ""type III collagen"", ""start_span"": 111, ""end_span"": 128, ""type"": ""Gene_or_gene_product""}, {""token"": ""pigment epithelium - derived factor"", ""start_span"": 133, ""end_span"": 168, ""type"": ""Gene_or_gene_product""}, {""token"": ""substratum"", ""start_span"": 194, ""end_span"": 204, ""type"": ""Cellular_component""}, {""token"": ""cells"", ""start_span"": 217, ""end_span"": 222, ""type"": ""Cell""}]"	train
Methotrexate ( MTX), a folic acid antagonist widely used for the treatment of a variety of tumors and inflammatory diseases, affects normal tissues that have a high rate of proliferation, including the hematopoietic cells of the bone marrow and the gastrointestinal mucosal cells.	Methotrexate,0,12,Chemical	MTX,15,18,Chemical	folic acid,23,33,Chemical	tumors,91,97,Cancer	normal tissues,133,147,Tissue	hematopoietic cells,202,221,Cell	bone marrow,229,240,Multi	gastrointestinal mucosal cells,249,279,Cell	"[{""token"": ""Methotrexate"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Chemical""}, {""token"": ""MTX"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Chemical""}, {""token"": ""folic acid"", ""start_span"": 23, ""end_span"": 33, ""type"": ""Chemical""}, {""token"": ""tumors"", ""start_span"": 91, ""end_span"": 97, ""type"": ""Cancer""}, {""token"": ""normal tissues"", ""start_span"": 133, ""end_span"": 147, ""type"": ""Tissue""}, {""token"": ""hematopoietic cells"", ""start_span"": 202, ""end_span"": 221, ""type"": ""Cell""}, {""token"": ""bone marrow"", ""start_span"": 229, ""end_span"": 240, ""type"": ""Multi""}, {""token"": ""gastrointestinal mucosal cells"", ""start_span"": 249, ""end_span"": 279, ""type"": ""Cell""}]"	train
Here, we show that NCAM - deficient beta cell tumors grew leaky blood vessels with perturbed pericyte - endothelial cell - cell interactions and deficient perivascular deposition of ECM components.	NCAM,19,23,Gene_or_gene_product	blood vessels,64,77,Multi	pericyte,93,101,Cell	endothelial,104,115,Cell	cell,116,120,Cell	cell,123,127,Cell	perivascular,155,167,Immaterial_anatomical_entity	ECM components,182,196,Cellular_component	"[{""token"": ""NCAM"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""blood vessels"", ""start_span"": 64, ""end_span"": 77, ""type"": ""Multi""}, {""token"": ""pericyte"", ""start_span"": 93, ""end_span"": 101, ""type"": ""Cell""}, {""token"": ""endothelial"", ""start_span"": 104, ""end_span"": 115, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 123, ""end_span"": 127, ""type"": ""Cell""}, {""token"": ""perivascular"", ""start_span"": 155, ""end_span"": 167, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""ECM components"", ""start_span"": 182, ""end_span"": 196, ""type"": ""Cellular_component""}]"	train
RESULTS: Opticin was immunolocalised to the basal cell surface and basement membrane material of the non - pigmented CBE in nine donor eyes as well as four hyperplastic lesions of the CBE ( Fuchs ' s adenoma).	Opticin,9,16,Gene_or_gene_product	basal cell surface,44,62,Cellular_component	basement membrane material,67,93,Cellular_component	non - pigmented CBE,101,120,Tissue	eyes,135,139,Organ	hyperplastic lesions,156,176,Cancer	CBE,184,187,Tissue	Fuchs ' s adenoma,190,207,Cancer	"[{""token"": ""Opticin"", ""start_span"": 9, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""basal cell surface"", ""start_span"": 44, ""end_span"": 62, ""type"": ""Cellular_component""}, {""token"": ""basement membrane material"", ""start_span"": 67, ""end_span"": 93, ""type"": ""Cellular_component""}, {""token"": ""non - pigmented CBE"", ""start_span"": 101, ""end_span"": 120, ""type"": ""Tissue""}, {""token"": ""eyes"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Organ""}, {""token"": ""hyperplastic lesions"", ""start_span"": 156, ""end_span"": 176, ""type"": ""Cancer""}, {""token"": ""CBE"", ""start_span"": 184, ""end_span"": 187, ""type"": ""Tissue""}, {""token"": ""Fuchs ' s adenoma"", ""start_span"": 190, ""end_span"": 207, ""type"": ""Cancer""}]"	train
Compared with their corresponding single mutant littermates, the p18 ( - / -); Men1 ( + / -) mice develop tumors at an accelerated rate and with an increased incidence in the pituitary, thyroid, parathyroid, and pancreas.	single mutant littermates,34,59,Organism	p18,65,68,Gene_or_gene_product	Men1,79,83,Gene_or_gene_product	tumors,106,112,Cancer	pituitary,175,184,Organ	thyroid,186,193,Organ	parathyroid,195,206,Organ	pancreas,212,220,Organ	"[{""token"": ""single mutant littermates"", ""start_span"": 34, ""end_span"": 59, ""type"": ""Organism""}, {""token"": ""p18"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""Men1"", ""start_span"": 79, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 106, ""end_span"": 112, ""type"": ""Cancer""}, {""token"": ""pituitary"", ""start_span"": 175, ""end_span"": 184, ""type"": ""Organ""}, {""token"": ""thyroid"", ""start_span"": 186, ""end_span"": 193, ""type"": ""Organ""}, {""token"": ""parathyroid"", ""start_span"": 195, ""end_span"": 206, ""type"": ""Organ""}, {""token"": ""pancreas"", ""start_span"": 212, ""end_span"": 220, ""type"": ""Organ""}]"	train
20 - HETE also increased the phosphorylation of p42 / p44 mitogen - activated protein kinase ( MAPK) in EC, whereas an inhibitor of MAPK [ U0126, 1, 4 - diamino - 2, 3 - dicyano - 1, 4 - bis ( 2 - aminophenylthio) butadiene] suppressed the proliferative and the VEGF changes but not the pro - oxidant effects of 20 - HETE.	20 - HETE,0,9,Chemical	p42 / p44 mitogen - activated protein kinase,48,92,Gene_or_gene_product	MAPK,95,99,Gene_or_gene_product	EC,104,106,Cell	MAPK,132,136,Gene_or_gene_product	U0126,139,144,Chemical	VEGF,262,266,Gene_or_gene_product	20 - HETE,312,321,Chemical	"[{""token"": ""20 - HETE"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical""}, {""token"": ""p42 / p44 mitogen - activated protein kinase"", ""start_span"": 48, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""MAPK"", ""start_span"": 95, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""EC"", ""start_span"": 104, ""end_span"": 106, ""type"": ""Cell""}, {""token"": ""MAPK"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}, {""token"": ""U0126"", ""start_span"": 139, ""end_span"": 144, ""type"": ""Chemical""}, {""token"": ""VEGF"", ""start_span"": 262, ""end_span"": 266, ""type"": ""Gene_or_gene_product""}, {""token"": ""20 - HETE"", ""start_span"": 312, ""end_span"": 321, ""type"": ""Chemical""}]"	train
Trib1 and Evi1 were up - regulated due to retroviral insertions, and coexpression of these genes significantly accelerated the onset of Hoxa9 / Meis1 - induced AML, suggesting that Trib1 and Evi1 are the key collaborators.	Trib1,0,5,Gene_or_gene_product	Evi1,10,14,Gene_or_gene_product	retroviral,42,52,Organism	Hoxa9,136,141,Gene_or_gene_product	Meis1,144,149,Gene_or_gene_product	AML,160,163,Cancer	Trib1,181,186,Gene_or_gene_product	Evi1,191,195,Gene_or_gene_product	"[{""token"": ""Trib1"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""Evi1"", ""start_span"": 10, ""end_span"": 14, ""type"": ""Gene_or_gene_product""}, {""token"": ""retroviral"", ""start_span"": 42, ""end_span"": 52, ""type"": ""Organism""}, {""token"": ""Hoxa9"", ""start_span"": 136, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}, {""token"": ""Meis1"", ""start_span"": 144, ""end_span"": 149, ""type"": ""Gene_or_gene_product""}, {""token"": ""AML"", ""start_span"": 160, ""end_span"": 163, ""type"": ""Cancer""}, {""token"": ""Trib1"", ""start_span"": 181, ""end_span"": 186, ""type"": ""Gene_or_gene_product""}, {""token"": ""Evi1"", ""start_span"": 191, ""end_span"": 195, ""type"": ""Gene_or_gene_product""}]"	train
The v - Src - transformed MEFs deficient in SWAP - 70 were unable to grow in soft agar while those expressing SWAP70 readily formed colonies, suggesting that SWAP - 70 is required for anchorage independent growth of v - Src transformed MEFs.	v - Src,4,11,Gene_or_gene_product	MEFs,26,30,Cell	SWAP - 70,44,53,Gene_or_gene_product	SWAP70,110,116,Gene_or_gene_product	colonies,132,140,Cell	SWAP - 70,158,167,Gene_or_gene_product	v - Src,216,223,Gene_or_gene_product	MEFs,236,240,Cell	"[{""token"": ""v - Src"", ""start_span"": 4, ""end_span"": 11, ""type"": ""Gene_or_gene_product""}, {""token"": ""MEFs"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Cell""}, {""token"": ""SWAP - 70"", ""start_span"": 44, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""SWAP70"", ""start_span"": 110, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""colonies"", ""start_span"": 132, ""end_span"": 140, ""type"": ""Cell""}, {""token"": ""SWAP - 70"", ""start_span"": 158, ""end_span"": 167, ""type"": ""Gene_or_gene_product""}, {""token"": ""v - Src"", ""start_span"": 216, ""end_span"": 223, ""type"": ""Gene_or_gene_product""}, {""token"": ""MEFs"", ""start_span"": 236, ""end_span"": 240, ""type"": ""Cell""}]"	train
Consequently, we examined by immunohistochemistry, using the avidin - biotin - peroxidase method, Bcl - xL, Bax, and p53 expression in 56 samples of primary oral squamous cell carcinoma and in 22 matched pairs of primary and metastatic tumors.	avidin,61,67,Gene_or_gene_product	biotin,70,76,Chemical	peroxidase,79,89,Gene_or_gene_product	Bcl - xL,98,106,Gene_or_gene_product	Bax,108,111,Gene_or_gene_product	p53,117,120,Gene_or_gene_product	oral squamous cell carcinoma,157,185,Cancer	metastatic tumors,225,242,Cancer	"[{""token"": ""avidin"", ""start_span"": 61, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""biotin"", ""start_span"": 70, ""end_span"": 76, ""type"": ""Chemical""}, {""token"": ""peroxidase"", ""start_span"": 79, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl - xL"", ""start_span"": 98, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bax"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 117, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""oral squamous cell carcinoma"", ""start_span"": 157, ""end_span"": 185, ""type"": ""Cancer""}, {""token"": ""metastatic tumors"", ""start_span"": 225, ""end_span"": 242, ""type"": ""Cancer""}]"	train
Treatment with the combination of 1B3 and DC101 in BxPC - 3 xenograft - bearing mice resulted in tumor regression in 58% of mice compared to that in 18% of mice treated with DC101 alone.	1B3,34,37,Chemical	DC101,42,47,Chemical	BxPC - 3 xenograft,51,69,Cancer	mice,80,84,Organism	tumor,97,102,Cancer	mice,124,128,Organism	mice,156,160,Organism	DC101,174,179,Chemical	"[{""token"": ""1B3"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Chemical""}, {""token"": ""DC101"", ""start_span"": 42, ""end_span"": 47, ""type"": ""Chemical""}, {""token"": ""BxPC - 3 xenograft"", ""start_span"": 51, ""end_span"": 69, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 80, ""end_span"": 84, ""type"": ""Organism""}, {""token"": ""tumor"", ""start_span"": 97, ""end_span"": 102, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 124, ""end_span"": 128, ""type"": ""Organism""}, {""token"": ""mice"", ""start_span"": 156, ""end_span"": 160, ""type"": ""Organism""}, {""token"": ""DC101"", ""start_span"": 174, ""end_span"": 179, ""type"": ""Chemical""}]"	train
METHODS: Human fat tissue fragments from surgery were placed in 96 - well plates, embedded in fibrin thrombin clot and overlaid with cell culture media containing 20% fetal bovine serum.	Human,9,14,Organism	fat tissue,15,25,Tissue	fibrin,94,100,Gene_or_gene_product	thrombin,101,109,Gene_or_gene_product	clot,110,114,Organism_substance	cell,133,137,Cell	bovine,173,179,Organism	serum,180,185,Organism_substance	"[{""token"": ""Human"", ""start_span"": 9, ""end_span"": 14, ""type"": ""Organism""}, {""token"": ""fat tissue"", ""start_span"": 15, ""end_span"": 25, ""type"": ""Tissue""}, {""token"": ""fibrin"", ""start_span"": 94, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""thrombin"", ""start_span"": 101, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""clot"", ""start_span"": 110, ""end_span"": 114, ""type"": ""Organism_substance""}, {""token"": ""cell"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Cell""}, {""token"": ""bovine"", ""start_span"": 173, ""end_span"": 179, ""type"": ""Organism""}, {""token"": ""serum"", ""start_span"": 180, ""end_span"": 185, ""type"": ""Organism_substance""}]"	train
Acquired molecular abnormalities ( mutations or chromosomal translocations) of the RUNX1 transcription factor gene are frequent in acute myeloblastic leukemias ( AMLs) and in therapy - related myelodysplastic syndromes, but rarely in acute lymphoblastic leukemias ( ALLs) and chronic myelogenous leukemias ( CMLs).	chromosomal,48,59,Cellular_component	RUNX1,83,88,Gene_or_gene_product	acute myeloblastic leukemias,131,159,Cancer	AMLs,162,166,Cancer	acute lymphoblastic leukemias,234,263,Cancer	ALLs,266,270,Cancer	chronic myelogenous leukemias,276,305,Cancer	CMLs,308,312,Cancer	"[{""token"": ""chromosomal"", ""start_span"": 48, ""end_span"": 59, ""type"": ""Cellular_component""}, {""token"": ""RUNX1"", ""start_span"": 83, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""acute myeloblastic leukemias"", ""start_span"": 131, ""end_span"": 159, ""type"": ""Cancer""}, {""token"": ""AMLs"", ""start_span"": 162, ""end_span"": 166, ""type"": ""Cancer""}, {""token"": ""acute lymphoblastic leukemias"", ""start_span"": 234, ""end_span"": 263, ""type"": ""Cancer""}, {""token"": ""ALLs"", ""start_span"": 266, ""end_span"": 270, ""type"": ""Cancer""}, {""token"": ""chronic myelogenous leukemias"", ""start_span"": 276, ""end_span"": 305, ""type"": ""Cancer""}, {""token"": ""CMLs"", ""start_span"": 308, ""end_span"": 312, ""type"": ""Cancer""}]"	train
In addition, we also report a high frequency of cryptic chromosomal RUNX1 translocation to a novel recently described gene partner, PRDM16 on chromosome 1p36, for 3 ( 21. 4%) of 14 investigated patients: 2 myeloid BC CMLs and, for the first time, 1 therapy - related BCR - ABL + ALL.	chromosomal,56,67,Cellular_component	RUNX1,68,73,Gene_or_gene_product	PRDM16,132,138,Gene_or_gene_product	chromosome 1p36,142,157,Cellular_component	patients,194,202,Organism	myeloid BC CMLs,206,221,Cancer	BCR,267,270,Gene_or_gene_product	ABL,273,276,Gene_or_gene_product	"[{""token"": ""chromosomal"", ""start_span"": 56, ""end_span"": 67, ""type"": ""Cellular_component""}, {""token"": ""RUNX1"", ""start_span"": 68, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""PRDM16"", ""start_span"": 132, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""chromosome 1p36"", ""start_span"": 142, ""end_span"": 157, ""type"": ""Cellular_component""}, {""token"": ""patients"", ""start_span"": 194, ""end_span"": 202, ""type"": ""Organism""}, {""token"": ""myeloid BC CMLs"", ""start_span"": 206, ""end_span"": 221, ""type"": ""Cancer""}, {""token"": ""BCR"", ""start_span"": 267, ""end_span"": 270, ""type"": ""Gene_or_gene_product""}, {""token"": ""ABL"", ""start_span"": 273, ""end_span"": 276, ""type"": ""Gene_or_gene_product""}]"	train
EXPERIMENTAL DESIGN: We used rAAV2 / 5 to deliver vasostatin intratumorally or systemically in different mouse lung tumor models - - subcutaneous, orthotopic xenograft, and spontaneous metastasis lung tumor models.	rAAV2,29,34,Organism	5,37,38,Organism	vasostatin,50,60,Gene_or_gene_product	intratumorally,61,75,Cancer	mouse,105,110,Organism	lung tumor,111,121,Cancer	xenograft,158,167,Cancer	lung tumor,196,206,Cancer	"[{""token"": ""rAAV2"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Organism""}, {""token"": ""5"", ""start_span"": 37, ""end_span"": 38, ""type"": ""Organism""}, {""token"": ""vasostatin"", ""start_span"": 50, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""intratumorally"", ""start_span"": 61, ""end_span"": 75, ""type"": ""Cancer""}, {""token"": ""mouse"", ""start_span"": 105, ""end_span"": 110, ""type"": ""Organism""}, {""token"": ""lung tumor"", ""start_span"": 111, ""end_span"": 121, ""type"": ""Cancer""}, {""token"": ""xenograft"", ""start_span"": 158, ""end_span"": 167, ""type"": ""Cancer""}, {""token"": ""lung tumor"", ""start_span"": 196, ""end_span"": 206, ""type"": ""Cancer""}]"	train
We did a blind prospective study in gastric cancer to assess the significance of isolated tumor cells ( ITC) and to test the hypothesis that vascular endothelial growth factor receptor - 1 ( VEGFR - 1) is expressed within the bone marrow at tumor - specific, premetastatic sites.	gastric cancer,36,50,Cancer	isolated tumor cells,81,101,Cell	ITC,104,107,Cell	vascular endothelial growth factor receptor - 1,141,188,Gene_or_gene_product	VEGFR - 1,191,200,Gene_or_gene_product	bone marrow,226,237,Multi	tumor,241,246,Cancer	premetastatic sites,259,278,Multi	"[{""token"": ""gastric cancer"", ""start_span"": 36, ""end_span"": 50, ""type"": ""Cancer""}, {""token"": ""isolated tumor cells"", ""start_span"": 81, ""end_span"": 101, ""type"": ""Cell""}, {""token"": ""ITC"", ""start_span"": 104, ""end_span"": 107, ""type"": ""Cell""}, {""token"": ""vascular endothelial growth factor receptor - 1"", ""start_span"": 141, ""end_span"": 188, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR - 1"", ""start_span"": 191, ""end_span"": 200, ""type"": ""Gene_or_gene_product""}, {""token"": ""bone marrow"", ""start_span"": 226, ""end_span"": 237, ""type"": ""Multi""}, {""token"": ""tumor"", ""start_span"": 241, ""end_span"": 246, ""type"": ""Cancer""}, {""token"": ""premetastatic sites"", ""start_span"": 259, ""end_span"": 278, ""type"": ""Multi""}]"	train
We previously reported that a single dose of ethanol ( 1. 4 g / kg), yielding a blood alcohol concentration of 100 mg / dl, significantly impairs angiogenesis in murine wounds, despite adequate levels of VEGF, suggesting direct effects of ethanol on endothelial cell signaling ( 40).	ethanol,45,52,Chemical	blood,80,85,Organism_substance	alcohol,86,93,Chemical	murine,162,168,Organism	wounds,169,175,Pathological_formation	VEGF,204,208,Gene_or_gene_product	ethanol,239,246,Chemical	endothelial cell,250,266,Cell	"[{""token"": ""ethanol"", ""start_span"": 45, ""end_span"": 52, ""type"": ""Chemical""}, {""token"": ""blood"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Organism_substance""}, {""token"": ""alcohol"", ""start_span"": 86, ""end_span"": 93, ""type"": ""Chemical""}, {""token"": ""murine"", ""start_span"": 162, ""end_span"": 168, ""type"": ""Organism""}, {""token"": ""wounds"", ""start_span"": 169, ""end_span"": 175, ""type"": ""Pathological_formation""}, {""token"": ""VEGF"", ""start_span"": 204, ""end_span"": 208, ""type"": ""Gene_or_gene_product""}, {""token"": ""ethanol"", ""start_span"": 239, ""end_span"": 246, ""type"": ""Chemical""}, {""token"": ""endothelial cell"", ""start_span"": 250, ""end_span"": 266, ""type"": ""Cell""}]"	train
Four weeks after cell transplantation, reverse transcriptase - polymerase chain reaction ( RT - PCR) and immunohistochemistry for vascular endothelial growth factor ( VEGF), VIII - factor immunohistochemistry for vessel density, TUNEL, caspase - 3 for cardiomyocyte apoptosis, echocardiography and hemodynamic detection for heart function were performed.	cell,17,21,Cell	vascular endothelial growth factor,130,164,Gene_or_gene_product	VEGF,167,171,Gene_or_gene_product	VIII - factor,174,187,Gene_or_gene_product	vessel,213,219,Multi	caspase - 3,236,247,Gene_or_gene_product	cardiomyocyte,252,265,Cell	heart,324,329,Organ	"[{""token"": ""cell"", ""start_span"": 17, ""end_span"": 21, ""type"": ""Cell""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 130, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 167, ""end_span"": 171, ""type"": ""Gene_or_gene_product""}, {""token"": ""VIII - factor"", ""start_span"": 174, ""end_span"": 187, ""type"": ""Gene_or_gene_product""}, {""token"": ""vessel"", ""start_span"": 213, ""end_span"": 219, ""type"": ""Multi""}, {""token"": ""caspase - 3"", ""start_span"": 236, ""end_span"": 247, ""type"": ""Gene_or_gene_product""}, {""token"": ""cardiomyocyte"", ""start_span"": 252, ""end_span"": 265, ""type"": ""Cell""}, {""token"": ""heart"", ""start_span"": 324, ""end_span"": 329, ""type"": ""Organ""}]"	train
Treatment of cultured human endothelial cells with DAPT, a gamma secretase inhibitor, increased cell migration and sprout formation in response to VEGF stimulation with a biphasic dependence on DAPT concentration.	human,22,27,Organism	endothelial cells,28,45,Cell	DAPT,51,55,Chemical	gamma secretase,59,74,Gene_or_gene_product	cell,96,100,Cell	sprout,115,121,Tissue	VEGF,147,151,Gene_or_gene_product	DAPT,194,198,Chemical	"[{""token"": ""human"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Organism""}, {""token"": ""endothelial cells"", ""start_span"": 28, ""end_span"": 45, ""type"": ""Cell""}, {""token"": ""DAPT"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Chemical""}, {""token"": ""gamma secretase"", ""start_span"": 59, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Cell""}, {""token"": ""sprout"", ""start_span"": 115, ""end_span"": 121, ""type"": ""Tissue""}, {""token"": ""VEGF"", ""start_span"": 147, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}, {""token"": ""DAPT"", ""start_span"": 194, ""end_span"": 198, ""type"": ""Chemical""}]"	train
Further, delivery of an appropriate combination of DAPT and VEGF from an injectable alginate hydrogel system into ischemic hindlimbs led to a faster recovery of blood flow than VEGF or DAPT alone; perfusion levels reached 80% of the normal level by week 4 with combined DAPT and VEGF delivery.	DAPT,51,55,Chemical	VEGF,60,64,Gene_or_gene_product	hindlimbs,123,132,Organism_subdivision	blood,161,166,Organism_substance	VEGF,177,181,Gene_or_gene_product	DAPT,185,189,Chemical	DAPT,270,274,Chemical	VEGF,279,283,Gene_or_gene_product	"[{""token"": ""DAPT"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Chemical""}, {""token"": ""VEGF"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""hindlimbs"", ""start_span"": 123, ""end_span"": 132, ""type"": ""Organism_subdivision""}, {""token"": ""blood"", ""start_span"": 161, ""end_span"": 166, ""type"": ""Organism_substance""}, {""token"": ""VEGF"", ""start_span"": 177, ""end_span"": 181, ""type"": ""Gene_or_gene_product""}, {""token"": ""DAPT"", ""start_span"": 185, ""end_span"": 189, ""type"": ""Chemical""}, {""token"": ""DAPT"", ""start_span"": 270, ""end_span"": 274, ""type"": ""Chemical""}, {""token"": ""VEGF"", ""start_span"": 279, ""end_span"": 283, ""type"": ""Gene_or_gene_product""}]"	train
Based on our results, we hypothesize that FGFR2 ( +) - TFs might provide cancer cells with a suitable microenvironment via secretion of proteins that could promote cancer development and progression through stimulation of cancer cell proliferation, induction of angiogenesis, inhibition of cell adhesion, enhancement of cell mobility, and promotion of the epithelial - mesenchymal transition.	FGFR2,42,47,Gene_or_gene_product	cancer cells,73,85,Cell	cancer,164,170,Cancer	cancer cell,222,233,Cell	cell,290,294,Cell	cell,320,324,Cell	epithelial,356,366,Cell	mesenchymal,369,380,Cell	"[{""token"": ""FGFR2"", ""start_span"": 42, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer cells"", ""start_span"": 73, ""end_span"": 85, ""type"": ""Cell""}, {""token"": ""cancer"", ""start_span"": 164, ""end_span"": 170, ""type"": ""Cancer""}, {""token"": ""cancer cell"", ""start_span"": 222, ""end_span"": 233, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 290, ""end_span"": 294, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 320, ""end_span"": 324, ""type"": ""Cell""}, {""token"": ""epithelial"", ""start_span"": 356, ""end_span"": 366, ""type"": ""Cell""}, {""token"": ""mesenchymal"", ""start_span"": 369, ""end_span"": 380, ""type"": ""Cell""}]"	train
The aims of the present study were to compare, in vitro and in vivo, the antiangiogenic and antitumor activities of metronomic irinotecan ( CPT - 11), oxaliplatin ( L - OHP) and 5 - fluorouracil ( 5 - FU) in colorectal cancer and to investigate the metronomic combination of these drugs.	antitumor,92,101,Cancer	irinotecan,127,137,Chemical	CPT - 11,140,148,Chemical	oxaliplatin,151,162,Chemical	L - OHP,165,172,Chemical	5 - fluorouracil,178,194,Chemical	5 - FU,197,203,Chemical	colorectal cancer,208,225,Cancer	"[{""token"": ""antitumor"", ""start_span"": 92, ""end_span"": 101, ""type"": ""Cancer""}, {""token"": ""irinotecan"", ""start_span"": 127, ""end_span"": 137, ""type"": ""Chemical""}, {""token"": ""CPT - 11"", ""start_span"": 140, ""end_span"": 148, ""type"": ""Chemical""}, {""token"": ""oxaliplatin"", ""start_span"": 151, ""end_span"": 162, ""type"": ""Chemical""}, {""token"": ""L - OHP"", ""start_span"": 165, ""end_span"": 172, ""type"": ""Chemical""}, {""token"": ""5 - fluorouracil"", ""start_span"": 178, ""end_span"": 194, ""type"": ""Chemical""}, {""token"": ""5 - FU"", ""start_span"": 197, ""end_span"": 203, ""type"": ""Chemical""}, {""token"": ""colorectal cancer"", ""start_span"": 208, ""end_span"": 225, ""type"": ""Cancer""}]"	train
In these breast cancers activated Akt fails to inactivate and re - localize FOXO3a to the cytoplasm, and nuclear - targeted FOXO3a does not induce cell death or cell cycle arrest.	breast cancers,9,23,Cancer	Akt,34,37,Gene_or_gene_product	FOXO3a,76,82,Gene_or_gene_product	cytoplasm,90,99,Organism_substance	nuclear,105,112,Cellular_component	FOXO3a,124,130,Gene_or_gene_product	cell,147,151,Cell	cell,161,165,Cell	"[{""token"": ""breast cancers"", ""start_span"": 9, ""end_span"": 23, ""type"": ""Cancer""}, {""token"": ""Akt"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""FOXO3a"", ""start_span"": 76, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""cytoplasm"", ""start_span"": 90, ""end_span"": 99, ""type"": ""Organism_substance""}, {""token"": ""nuclear"", ""start_span"": 105, ""end_span"": 112, ""type"": ""Cellular_component""}, {""token"": ""FOXO3a"", ""start_span"": 124, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 147, ""end_span"": 151, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 161, ""end_span"": 165, ""type"": ""Cell""}]"	train
We have established a model system to detect the presence of ras p21 in the sera of Balb / c mice carrying tumors induced by a mouse cell line transformed with the Harvey murine sarcoma virus in the presence of a helper Friend murine leukemia virus.	ras p21,61,68,Gene_or_gene_product	sera,76,80,Organism_substance	Balb / c mice,84,97,Organism	tumors,107,113,Cancer	mouse,127,132,Organism	cell line,133,142,Cell	Harvey murine sarcoma virus,164,191,Organism	Friend murine leukemia virus,220,248,Organism	"[{""token"": ""ras p21"", ""start_span"": 61, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""sera"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Organism_substance""}, {""token"": ""Balb / c mice"", ""start_span"": 84, ""end_span"": 97, ""type"": ""Organism""}, {""token"": ""tumors"", ""start_span"": 107, ""end_span"": 113, ""type"": ""Cancer""}, {""token"": ""mouse"", ""start_span"": 127, ""end_span"": 132, ""type"": ""Organism""}, {""token"": ""cell line"", ""start_span"": 133, ""end_span"": 142, ""type"": ""Cell""}, {""token"": ""Harvey murine sarcoma virus"", ""start_span"": 164, ""end_span"": 191, ""type"": ""Organism""}, {""token"": ""Friend murine leukemia virus"", ""start_span"": 220, ""end_span"": 248, ""type"": ""Organism""}]"	train
Since ras genes have been found to be frequently activated in human tumours, we examined the levels of ras p21 in the sera of a variety of human cancer patients.	ras,6,9,Gene_or_gene_product	human,62,67,Organism	tumours,68,75,Cancer	ras p21,103,110,Gene_or_gene_product	sera,118,122,Organism_substance	human,139,144,Organism	cancer,145,151,Cancer	patients,152,160,Organism	"[{""token"": ""ras"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Organism""}, {""token"": ""tumours"", ""start_span"": 68, ""end_span"": 75, ""type"": ""Cancer""}, {""token"": ""ras p21"", ""start_span"": 103, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""sera"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Organism_substance""}, {""token"": ""human"", ""start_span"": 139, ""end_span"": 144, ""type"": ""Organism""}, {""token"": ""cancer"", ""start_span"": 145, ""end_span"": 151, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 152, ""end_span"": 160, ""type"": ""Organism""}]"	train
We concluded that RAF265 is highly efficacious in this xenograft model of human melanoma and decreases glucose metabolism as measured by DNA microarray analysis, cell culture assays, and small animal FDG PET scans as early as 1 day after treatment.	RAF265,18,24,Chemical	xenograft,55,64,Cancer	human,74,79,Organism	melanoma,80,88,Cancer	glucose,103,110,Chemical	DNA,137,140,Cellular_component	cell,162,166,Cell	FDG,200,203,Chemical	"[{""token"": ""RAF265"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Chemical""}, {""token"": ""xenograft"", ""start_span"": 55, ""end_span"": 64, ""type"": ""Cancer""}, {""token"": ""human"", ""start_span"": 74, ""end_span"": 79, ""type"": ""Organism""}, {""token"": ""melanoma"", ""start_span"": 80, ""end_span"": 88, ""type"": ""Cancer""}, {""token"": ""glucose"", ""start_span"": 103, ""end_span"": 110, ""type"": ""Chemical""}, {""token"": ""DNA"", ""start_span"": 137, ""end_span"": 140, ""type"": ""Cellular_component""}, {""token"": ""cell"", ""start_span"": 162, ""end_span"": 166, ""type"": ""Cell""}, {""token"": ""FDG"", ""start_span"": 200, ""end_span"": 203, ""type"": ""Chemical""}]"	train
Sunitinib induces apoptosis in pheochromocytoma tumor cells by inhibiting VEGFR2 / Akt / mTOR / S6K1 pathways through modulation of Bcl - 2 and BAD.	Sunitinib,0,9,Chemical	pheochromocytoma tumor cells,31,59,Cell	VEGFR2,74,80,Gene_or_gene_product	Akt,83,86,Gene_or_gene_product	mTOR,89,93,Gene_or_gene_product	S6K1,96,100,Gene_or_gene_product	Bcl - 2,132,139,Gene_or_gene_product	BAD,144,147,Gene_or_gene_product	"[{""token"": ""Sunitinib"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical""}, {""token"": ""pheochromocytoma tumor cells"", ""start_span"": 31, ""end_span"": 59, ""type"": ""Cell""}, {""token"": ""VEGFR2"", ""start_span"": 74, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 83, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""mTOR"", ""start_span"": 89, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}, {""token"": ""S6K1"", ""start_span"": 96, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl - 2"", ""start_span"": 132, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}, {""token"": ""BAD"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}]"	train
Thus, these results together suggest that sunitinib initially exerts its apoptotic effect through the inhibition of VEGFR - 2, which, when followed by reduction of its downstream effectors, including Akt / mTOR / S6K1, may lead to inhibition of the antiapoptotic molecule Bcl - 2 and activation of the proapoptotic molecule BAD in PC12 cells.	sunitinib,42,51,Chemical	VEGFR - 2,116,125,Gene_or_gene_product	Akt,200,203,Gene_or_gene_product	mTOR,206,210,Gene_or_gene_product	S6K1,213,217,Gene_or_gene_product	Bcl - 2,272,279,Gene_or_gene_product	BAD,324,327,Gene_or_gene_product	PC12 cells,331,341,Cell	"[{""token"": ""sunitinib"", ""start_span"": 42, ""end_span"": 51, ""type"": ""Chemical""}, {""token"": ""VEGFR - 2"", ""start_span"": 116, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 200, ""end_span"": 203, ""type"": ""Gene_or_gene_product""}, {""token"": ""mTOR"", ""start_span"": 206, ""end_span"": 210, ""type"": ""Gene_or_gene_product""}, {""token"": ""S6K1"", ""start_span"": 213, ""end_span"": 217, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl - 2"", ""start_span"": 272, ""end_span"": 279, ""type"": ""Gene_or_gene_product""}, {""token"": ""BAD"", ""start_span"": 324, ""end_span"": 327, ""type"": ""Gene_or_gene_product""}, {""token"": ""PC12 cells"", ""start_span"": 331, ""end_span"": 341, ""type"": ""Cell""}]"	train
Using isogenic human mammary epithelial cells ( HMEC) at different stages of neoplastic transformation, we found that OSM signaling suppressed c - MYC expression and engaged a p16 - and p53 - independent growth arrest that required STAT3 activity.	human,15,20,Organism	mammary epithelial cells,21,45,Cell	HMEC,48,52,Cell	OSM,118,121,Gene_or_gene_product	c - MYC,143,150,Gene_or_gene_product	p16,176,179,Gene_or_gene_product	p53,186,189,Gene_or_gene_product	STAT3,232,237,Gene_or_gene_product	"[{""token"": ""human"", ""start_span"": 15, ""end_span"": 20, ""type"": ""Organism""}, {""token"": ""mammary epithelial cells"", ""start_span"": 21, ""end_span"": 45, ""type"": ""Cell""}, {""token"": ""HMEC"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Cell""}, {""token"": ""OSM"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - MYC"", ""start_span"": 143, ""end_span"": 150, ""type"": ""Gene_or_gene_product""}, {""token"": ""p16"", ""start_span"": 176, ""end_span"": 179, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 186, ""end_span"": 189, ""type"": ""Gene_or_gene_product""}, {""token"": ""STAT3"", ""start_span"": 232, ""end_span"": 237, ""type"": ""Gene_or_gene_product""}]"	train
Pthrp ablation in the mammary epithelium of the PyMT - MMTV breast cancer mouse model caused a delay in primary tumor initiation, inhibited tumor progression, and reduced metastasis to distal sites.	Pthrp,0,5,Gene_or_gene_product	mammary epithelium,22,40,Tissue	PyMT,48,52,Gene_or_gene_product	MMTV,55,59,Organism	breast cancer,60,73,Cancer	mouse,74,79,Organism	tumor,112,117,Cancer	tumor,140,145,Cancer	"[{""token"": ""Pthrp"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""mammary epithelium"", ""start_span"": 22, ""end_span"": 40, ""type"": ""Tissue""}, {""token"": ""PyMT"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMTV"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Organism""}, {""token"": ""breast cancer"", ""start_span"": 60, ""end_span"": 73, ""type"": ""Cancer""}, {""token"": ""mouse"", ""start_span"": 74, ""end_span"": 79, ""type"": ""Organism""}, {""token"": ""tumor"", ""start_span"": 112, ""end_span"": 117, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 140, ""end_span"": 145, ""type"": ""Cancer""}]"	train
The antiproliferative and anti - migratory mechanisms of HTPB were investigated by cell proliferation, flow cytometry, DNA ladder, caspase activity, Rho activity, F - actin polymerization, and gelatin - zymography for matrix metalloproteinases ( MMPs).	HTPB,57,61,Chemical	cell,83,87,Cell	DNA,119,122,Cellular_component	caspase,131,138,Gene_or_gene_product	Rho,149,152,Gene_or_gene_product	F - actin,163,172,Gene_or_gene_product	matrix metalloproteinases,218,243,Gene_or_gene_product	MMPs,246,250,Gene_or_gene_product	"[{""token"": ""HTPB"", ""start_span"": 57, ""end_span"": 61, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Cell""}, {""token"": ""DNA"", ""start_span"": 119, ""end_span"": 122, ""type"": ""Cellular_component""}, {""token"": ""caspase"", ""start_span"": 131, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rho"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Gene_or_gene_product""}, {""token"": ""F - actin"", ""start_span"": 163, ""end_span"": 172, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix metalloproteinases"", ""start_span"": 218, ""end_span"": 243, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMPs"", ""start_span"": 246, ""end_span"": 250, ""type"": ""Gene_or_gene_product""}]"	train
The B ( 1) R appeared either as cytoplasmic dots or labeling on the apical cell membrane of the cells composing the epithelia with intestinal metaplasia ( 24 / 24; 100%) and carcinoma in situ ( 10 / 10; 100%) and in the epithelial cells of adenomas.	cytoplasmic,32,43,Organism_substance	apical cell membrane,68,88,Cellular_component	cells,96,101,Cell	epithelia,116,125,Tissue	intestinal metaplasia,131,152,Cancer	carcinoma in situ,174,191,Cancer	epithelial cells,220,236,Cell	adenomas,240,248,Cancer	"[{""token"": ""cytoplasmic"", ""start_span"": 32, ""end_span"": 43, ""type"": ""Organism_substance""}, {""token"": ""apical cell membrane"", ""start_span"": 68, ""end_span"": 88, ""type"": ""Cellular_component""}, {""token"": ""cells"", ""start_span"": 96, ""end_span"": 101, ""type"": ""Cell""}, {""token"": ""epithelia"", ""start_span"": 116, ""end_span"": 125, ""type"": ""Tissue""}, {""token"": ""intestinal metaplasia"", ""start_span"": 131, ""end_span"": 152, ""type"": ""Cancer""}, {""token"": ""carcinoma in situ"", ""start_span"": 174, ""end_span"": 191, ""type"": ""Cancer""}, {""token"": ""epithelial cells"", ""start_span"": 220, ""end_span"": 236, ""type"": ""Cell""}, {""token"": ""adenomas"", ""start_span"": 240, ""end_span"": 248, ""type"": ""Cancer""}]"	train
Expression of bFGF on normal human tissues was ubiquitously detected in the basement membranes of all size blood vessels, but was not found in epidermal or epithelial basement membranes of a variety of tissues tested.	bFGF,14,18,Gene_or_gene_product	human,29,34,Organism	tissues,35,42,Tissue	basement membranes,76,94,Cellular_component	blood vessels,107,120,Multi	epidermal,143,152,Cellular_component	epithelial basement membranes,156,185,Cellular_component	tissues,202,209,Tissue	"[{""token"": ""bFGF"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Organism""}, {""token"": ""tissues"", ""start_span"": 35, ""end_span"": 42, ""type"": ""Tissue""}, {""token"": ""basement membranes"", ""start_span"": 76, ""end_span"": 94, ""type"": ""Cellular_component""}, {""token"": ""blood vessels"", ""start_span"": 107, ""end_span"": 120, ""type"": ""Multi""}, {""token"": ""epidermal"", ""start_span"": 143, ""end_span"": 152, ""type"": ""Cellular_component""}, {""token"": ""epithelial basement membranes"", ""start_span"": 156, ""end_span"": 185, ""type"": ""Cellular_component""}, {""token"": ""tissues"", ""start_span"": 202, ""end_span"": 209, ""type"": ""Tissue""}]"	train
In contrast, no leukemia was observed with a myb IRES virus, with spliced vectors containing v - erbA alone or v - erbA in combination with v - myb, nor with erbA IRES and erbA / myb IRES viruses produced in the absence of helper virus.	leukemia,16,24,Cancer	myb,45,48,Gene_or_gene_product	v - erbA,93,101,Gene_or_gene_product	v - erbA,111,119,Gene_or_gene_product	v - myb,140,147,Gene_or_gene_product	erbA,158,162,Gene_or_gene_product	erbA,172,176,Gene_or_gene_product	myb,179,182,Gene_or_gene_product	"[{""token"": ""leukemia"", ""start_span"": 16, ""end_span"": 24, ""type"": ""Cancer""}, {""token"": ""myb"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""v - erbA"", ""start_span"": 93, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""v - erbA"", ""start_span"": 111, ""end_span"": 119, ""type"": ""Gene_or_gene_product""}, {""token"": ""v - myb"", ""start_span"": 140, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}, {""token"": ""erbA"", ""start_span"": 158, ""end_span"": 162, ""type"": ""Gene_or_gene_product""}, {""token"": ""erbA"", ""start_span"": 172, ""end_span"": 176, ""type"": ""Gene_or_gene_product""}, {""token"": ""myb"", ""start_span"": 179, ""end_span"": 182, ""type"": ""Gene_or_gene_product""}]"	train
Lysates of cells from the granulocyte - macrophage colony - stimulating factor ( GM - CSF) - dependent myeloid leukemic cell line TF1 were separated into high molecular weight ( HMW) pellets of intact DNA and supernatants of fragmented low MW ( LMW) DNA, and the DNA purified from these fractions was quantified.	Lysates,0,7,Organism_substance	cells,11,16,Cell	granulocyte - macrophage colony - stimulating factor,26,78,Gene_or_gene_product	GM - CSF,81,89,Gene_or_gene_product	myeloid leukemic cell line TF1,103,133,Cell	DNA,201,204,Cellular_component	DNA,250,253,Cellular_component	DNA,263,266,Cellular_component	"[{""token"": ""Lysates"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Organism_substance""}, {""token"": ""cells"", ""start_span"": 11, ""end_span"": 16, ""type"": ""Cell""}, {""token"": ""granulocyte - macrophage colony - stimulating factor"", ""start_span"": 26, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""GM - CSF"", ""start_span"": 81, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""myeloid leukemic cell line TF1"", ""start_span"": 103, ""end_span"": 133, ""type"": ""Cell""}, {""token"": ""DNA"", ""start_span"": 201, ""end_span"": 204, ""type"": ""Cellular_component""}, {""token"": ""DNA"", ""start_span"": 250, ""end_span"": 253, ""type"": ""Cellular_component""}, {""token"": ""DNA"", ""start_span"": 263, ""end_span"": 266, ""type"": ""Cellular_component""}]"	train
Thus, these data demonstrate cooperative mechanisms for VPF / VEGF regulation of EC migration involving the alphavbeta3 integrin, the alphavbeta3 ligand OPN, and thrombin cleavage of OPN.	VPF,56,59,Gene_or_gene_product	VEGF,62,66,Gene_or_gene_product	EC,81,83,Cell	alphavbeta3 integrin,108,128,Gene_or_gene_product	alphavbeta3,134,145,Gene_or_gene_product	OPN,153,156,Gene_or_gene_product	thrombin,162,170,Gene_or_gene_product	OPN,183,186,Gene_or_gene_product	"[{""token"": ""VPF"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""EC"", ""start_span"": 81, ""end_span"": 83, ""type"": ""Cell""}, {""token"": ""alphavbeta3 integrin"", ""start_span"": 108, ""end_span"": 128, ""type"": ""Gene_or_gene_product""}, {""token"": ""alphavbeta3"", ""start_span"": 134, ""end_span"": 145, ""type"": ""Gene_or_gene_product""}, {""token"": ""OPN"", ""start_span"": 153, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}, {""token"": ""thrombin"", ""start_span"": 162, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}, {""token"": ""OPN"", ""start_span"": 183, ""end_span"": 186, ""type"": ""Gene_or_gene_product""}]"	train
We demonstrate directly that the wild - type 55 - kDa protein is able to block E1A - induced p53 - dependent apoptosis, whereas cells infected by mutant pm490 / 1 / 5A, which contains alanine residues at all three phosphorylation sites, exhibited extensive DNA fragmentation and classic apoptotic cell death.	55 - kDa,45,53,Gene_or_gene_product	E1A,79,82,Gene_or_gene_product	p53,93,96,Gene_or_gene_product	cells,128,133,Cell	mutant pm490 / 1 / 5A,146,167,Organism	alanine,184,191,Amino_acid	DNA,257,260,Cellular_component	cell,297,301,Cell	"[{""token"": ""55 - kDa"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""E1A"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 128, ""end_span"": 133, ""type"": ""Cell""}, {""token"": ""mutant pm490 / 1 / 5A"", ""start_span"": 146, ""end_span"": 167, ""type"": ""Organism""}, {""token"": ""alanine"", ""start_span"": 184, ""end_span"": 191, ""type"": ""Amino_acid""}, {""token"": ""DNA"", ""start_span"": 257, ""end_span"": 260, ""type"": ""Cellular_component""}, {""token"": ""cell"", ""start_span"": 297, ""end_span"": 301, ""type"": ""Cell""}]"	train
Assuming discrimination thresholds between high - grade and low - grade tumours of 0. 8 for 18F - FDG uptake and 1. 8 for 123I - IMT uptake, the accuracy values of 18F - FDG PET and 123I - IMT SPET for differentiating between high - grade and low - grade tumours were 21 / 23 ( 91%) and 19 / 23 ( 83%), respectively.	high - grade,43,55,Cancer	low - grade tumours,60,79,Cancer	18F - FDG,92,101,Chemical	123I - IMT,122,132,Chemical	18F - FDG,164,173,Chemical	123I - IMT,182,192,Chemical	high - grade,226,238,Cancer	low - grade tumours,243,262,Cancer	"[{""token"": ""high - grade"", ""start_span"": 43, ""end_span"": 55, ""type"": ""Cancer""}, {""token"": ""low - grade tumours"", ""start_span"": 60, ""end_span"": 79, ""type"": ""Cancer""}, {""token"": ""18F - FDG"", ""start_span"": 92, ""end_span"": 101, ""type"": ""Chemical""}, {""token"": ""123I - IMT"", ""start_span"": 122, ""end_span"": 132, ""type"": ""Chemical""}, {""token"": ""18F - FDG"", ""start_span"": 164, ""end_span"": 173, ""type"": ""Chemical""}, {""token"": ""123I - IMT"", ""start_span"": 182, ""end_span"": 192, ""type"": ""Chemical""}, {""token"": ""high - grade"", ""start_span"": 226, ""end_span"": 238, ""type"": ""Cancer""}, {""token"": ""low - grade tumours"", ""start_span"": 243, ""end_span"": 262, ""type"": ""Cancer""}]"	train
The primary results indicated ( i) positive results of in situ hybridization are presence of granules or masses in the cytoplasm; ( ii) the less expression of nm23 - H1 mRNA, the higher metastatic rate of the human hepatocellular carcinoma ( P < 0. 05); ( iii) expression of nm23 - H1 mRNA dose not correlate with some other factors such as tumor size and the background of other liver diseases.	granules,93,101,Cellular_component	cytoplasm,119,128,Organism_substance	nm23 - H1,159,168,Gene_or_gene_product	human,209,214,Organism	hepatocellular carcinoma,215,239,Cancer	nm23 - H1,275,284,Gene_or_gene_product	tumor,341,346,Cancer	liver,380,385,Organ	"[{""token"": ""granules"", ""start_span"": 93, ""end_span"": 101, ""type"": ""Cellular_component""}, {""token"": ""cytoplasm"", ""start_span"": 119, ""end_span"": 128, ""type"": ""Organism_substance""}, {""token"": ""nm23 - H1"", ""start_span"": 159, ""end_span"": 168, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 209, ""end_span"": 214, ""type"": ""Organism""}, {""token"": ""hepatocellular carcinoma"", ""start_span"": 215, ""end_span"": 239, ""type"": ""Cancer""}, {""token"": ""nm23 - H1"", ""start_span"": 275, ""end_span"": 284, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 341, ""end_span"": 346, ""type"": ""Cancer""}, {""token"": ""liver"", ""start_span"": 380, ""end_span"": 385, ""type"": ""Organ""}]"	train
We produced a transgenic mouse line that expresses simian virus ( SV40) transforming sequences under control of the 1. 4 kb tyrosinase - related protein 1 ( TRP - 1) promoter, targeting expression of T antigen ( Tag) to the RPE.	mouse,25,30,Organism	simian virus,51,63,Organism	SV40,66,70,Organism	tyrosinase - related protein 1,124,154,Gene_or_gene_product	TRP - 1,157,164,Gene_or_gene_product	T antigen,200,209,Gene_or_gene_product	Tag,212,215,Gene_or_gene_product	RPE,224,227,Tissue	"[{""token"": ""mouse"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Organism""}, {""token"": ""simian virus"", ""start_span"": 51, ""end_span"": 63, ""type"": ""Organism""}, {""token"": ""SV40"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Organism""}, {""token"": ""tyrosinase - related protein 1"", ""start_span"": 124, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}, {""token"": ""TRP - 1"", ""start_span"": 157, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}, {""token"": ""T antigen"", ""start_span"": 200, ""end_span"": 209, ""type"": ""Gene_or_gene_product""}, {""token"": ""Tag"", ""start_span"": 212, ""end_span"": 215, ""type"": ""Gene_or_gene_product""}, {""token"": ""RPE"", ""start_span"": 224, ""end_span"": 227, ""type"": ""Tissue""}]"	train
No significant association was demonstrated between VEGF - B, VEGF - C, flt - 1, KDR, and flt - 4 with patient sex, patient age, or tumor size ( P greater than 0. 05).	VEGF - B,52,60,Gene_or_gene_product	VEGF - C,62,70,Gene_or_gene_product	flt - 1,72,79,Gene_or_gene_product	KDR,81,84,Gene_or_gene_product	flt - 4,90,97,Gene_or_gene_product	patient,103,110,Organism	patient,116,123,Organism	tumor,132,137,Cancer	"[{""token"": ""VEGF - B"", ""start_span"": 52, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - C"", ""start_span"": 62, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""flt - 1"", ""start_span"": 72, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""flt - 4"", ""start_span"": 90, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}, {""token"": ""patient"", ""start_span"": 103, ""end_span"": 110, ""type"": ""Organism""}, {""token"": ""patient"", ""start_span"": 116, ""end_span"": 123, ""type"": ""Organism""}, {""token"": ""tumor"", ""start_span"": 132, ""end_span"": 137, ""type"": ""Cancer""}]"	valid
The study shows that clear cell tumors are able to up - regulate angiogenic growth factor receptors more efficiently than chromophil ( papillary), that clear cell tumors can use pathways independent of VHL to regulate angiogenesis, and that this combined regulation may account for their more aggressive phenotype, which suggests that targeting VEGFR1 ( flt - l) may be particularly effective in these tumor types.	clear cell tumors,21,38,Cancer	chromophil,122,132,Cancer	papillary,135,144,Cancer	clear cell tumors,152,169,Cancer	VHL,202,205,Gene_or_gene_product	VEGFR1,345,351,Gene_or_gene_product	flt - l,354,361,Gene_or_gene_product	tumor,402,407,Cancer	"[{""token"": ""clear cell tumors"", ""start_span"": 21, ""end_span"": 38, ""type"": ""Cancer""}, {""token"": ""chromophil"", ""start_span"": 122, ""end_span"": 132, ""type"": ""Cancer""}, {""token"": ""papillary"", ""start_span"": 135, ""end_span"": 144, ""type"": ""Cancer""}, {""token"": ""clear cell tumors"", ""start_span"": 152, ""end_span"": 169, ""type"": ""Cancer""}, {""token"": ""VHL"", ""start_span"": 202, ""end_span"": 205, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR1"", ""start_span"": 345, ""end_span"": 351, ""type"": ""Gene_or_gene_product""}, {""token"": ""flt - l"", ""start_span"": 354, ""end_span"": 361, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 402, ""end_span"": 407, ""type"": ""Cancer""}]"	valid
The mammalian proto - oncogene Cbl and its cellular homologues in Caenorhabditis elegans ( Sli - 1) and Drosophila ( D - Cbl) are negative regulators of some growth factor receptor signaling pathways.	mammalian,4,13,Organism	Cbl,31,34,Gene_or_gene_product	cellular,43,51,Cell	Caenorhabditis elegans,66,88,Organism	Sli - 1,91,98,Gene_or_gene_product	Drosophila,104,114,Organism	D - Cbl,117,124,Gene_or_gene_product	growth factor receptor,158,180,Gene_or_gene_product	"[{""token"": ""mammalian"", ""start_span"": 4, ""end_span"": 13, ""type"": ""Organism""}, {""token"": ""Cbl"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 43, ""end_span"": 51, ""type"": ""Cell""}, {""token"": ""Caenorhabditis elegans"", ""start_span"": 66, ""end_span"": 88, ""type"": ""Organism""}, {""token"": ""Sli - 1"", ""start_span"": 91, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""Drosophila"", ""start_span"": 104, ""end_span"": 114, ""type"": ""Organism""}, {""token"": ""D - Cbl"", ""start_span"": 117, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}, {""token"": ""growth factor receptor"", ""start_span"": 158, ""end_span"": 180, ""type"": ""Gene_or_gene_product""}]"	valid
These results indicated that Crk plays a critical role in Rac1 - induced membrane ruffling and Rap1 - mediated nascent focal complex stabilization contributing to ephrin - B1 - induced human aortic endothelial cells migration.	Crk,29,32,Gene_or_gene_product	Rac1,58,62,Gene_or_gene_product	membrane,73,81,Cellular_component	Rap1,95,99,Gene_or_gene_product	nascent focal complex,111,132,Cellular_component	ephrin - B1,163,174,Gene_or_gene_product	human,185,190,Organism	aortic endothelial cells,191,215,Cell	"[{""token"": ""Crk"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""Rac1"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""membrane"", ""start_span"": 73, ""end_span"": 81, ""type"": ""Cellular_component""}, {""token"": ""Rap1"", ""start_span"": 95, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""nascent focal complex"", ""start_span"": 111, ""end_span"": 132, ""type"": ""Cellular_component""}, {""token"": ""ephrin - B1"", ""start_span"": 163, ""end_span"": 174, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 185, ""end_span"": 190, ""type"": ""Organism""}, {""token"": ""aortic endothelial cells"", ""start_span"": 191, ""end_span"": 215, ""type"": ""Cell""}]"	valid
Binding of factor VIIa ( FVIIa) to its cellular receptor tissue factor ( TF) was previously shown to induce various intracellular signaling events, which were thought to be responsible for TF - mediated biologic effects, including angiogenesis, tumor metastasis, and restenosis.	factor VIIa,11,22,Gene_or_gene_product	FVIIa,25,30,Gene_or_gene_product	cellular,39,47,Cell	tissue factor,57,70,Gene_or_gene_product	TF,73,75,Gene_or_gene_product	intracellular,116,129,Immaterial_anatomical_entity	TF,189,191,Gene_or_gene_product	tumor,245,250,Cancer	"[{""token"": ""factor VIIa"", ""start_span"": 11, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""FVIIa"", ""start_span"": 25, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 39, ""end_span"": 47, ""type"": ""Cell""}, {""token"": ""tissue factor"", ""start_span"": 57, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""TF"", ""start_span"": 73, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""intracellular"", ""start_span"": 116, ""end_span"": 129, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""TF"", ""start_span"": 189, ""end_span"": 191, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 245, ""end_span"": 250, ""type"": ""Cancer""}]"	valid
Besides TGFbeta and RTK / Ras signaling, autocrine factors and Wnt -, Notch -, Hedgehog - and NF - kappaB - dependent pathways were found to contribute to EMT.	TGFbeta,8,15,Gene_or_gene_product	RTK,20,23,Gene_or_gene_product	Ras,26,29,Gene_or_gene_product	Wnt,63,66,Gene_or_gene_product	Notch,70,75,Gene_or_gene_product	Hedgehog,79,87,Gene_or_gene_product	NF - kappaB,94,105,Gene_or_gene_product	EMT,155,158,Gene_or_gene_product	"[{""token"": ""TGFbeta"", ""start_span"": 8, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""RTK"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ras"", ""start_span"": 26, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""Wnt"", ""start_span"": 63, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""Notch"", ""start_span"": 70, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""Hedgehog"", ""start_span"": 79, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 94, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""EMT"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}]"	valid
Given the dominant role of p21 in p53 cell cycle control, we crossed Trp53 ( 515C / 515C) mice onto a p21 - null background to determine whether p21 was required for maintaining chromosomal stability and delaying tumor onset.	p21,27,30,Gene_or_gene_product	p53,34,37,Gene_or_gene_product	cell,38,42,Cell	Trp53,69,74,Gene_or_gene_product	p21,102,105,Gene_or_gene_product	p21,145,148,Gene_or_gene_product	chromosomal,178,189,Cellular_component	tumor,213,218,Cancer	"[{""token"": ""p21"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 34, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Cell""}, {""token"": ""Trp53"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""p21"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""p21"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Gene_or_gene_product""}, {""token"": ""chromosomal"", ""start_span"": 178, ""end_span"": 189, ""type"": ""Cellular_component""}, {""token"": ""tumor"", ""start_span"": 213, ""end_span"": 218, ""type"": ""Cancer""}]"	valid
Cytogenetic examination of Trp53 ( 515C / 515C) p21 ( - / -) sarcomas and lymphomas revealed aneuploidy and chromosomal aberrations that were absent in Trp53 ( 515C / 515C) malignancies.	Trp53,27,32,Gene_or_gene_product	p21,48,51,Gene_or_gene_product	sarcomas,61,69,Cancer	lymphomas,74,83,Cancer	aneuploidy,93,103,Pathological_formation	chromosomal aberrations,108,131,Pathological_formation	Trp53,152,157,Gene_or_gene_product	malignancies,173,185,Cancer	"[{""token"": ""Trp53"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""p21"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""sarcomas"", ""start_span"": 61, ""end_span"": 69, ""type"": ""Cancer""}, {""token"": ""lymphomas"", ""start_span"": 74, ""end_span"": 83, ""type"": ""Cancer""}, {""token"": ""aneuploidy"", ""start_span"": 93, ""end_span"": 103, ""type"": ""Pathological_formation""}, {""token"": ""chromosomal aberrations"", ""start_span"": 108, ""end_span"": 131, ""type"": ""Pathological_formation""}, {""token"": ""Trp53"", ""start_span"": 152, ""end_span"": 157, ""type"": ""Gene_or_gene_product""}, {""token"": ""malignancies"", ""start_span"": 173, ""end_span"": 185, ""type"": ""Cancer""}]"	valid
Induction of gelatinases ( matrix metalloproteinase 2 and 9), the serine protease tissue plasminogen activator and plasmin by DCN transfection in MCE cells leads to extracellular proteolysis and to release of matrix - bound VEGF and activation of angiogenesis.	matrix metalloproteinase 2,27,53,Gene_or_gene_product	9,58,59,Gene_or_gene_product	tissue plasminogen activator,82,110,Gene_or_gene_product	plasmin,115,122,Gene_or_gene_product	DCN,126,129,Gene_or_gene_product	MCE cells,146,155,Cell	extracellular,165,178,Immaterial_anatomical_entity	VEGF,224,228,Gene_or_gene_product	"[{""token"": ""matrix metalloproteinase 2"", ""start_span"": 27, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""9"", ""start_span"": 58, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""tissue plasminogen activator"", ""start_span"": 82, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""plasmin"", ""start_span"": 115, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""DCN"", ""start_span"": 126, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""MCE cells"", ""start_span"": 146, ""end_span"": 155, ""type"": ""Cell""}, {""token"": ""extracellular"", ""start_span"": 165, ""end_span"": 178, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""VEGF"", ""start_span"": 224, ""end_span"": 228, ""type"": ""Gene_or_gene_product""}]"	valid
Cediranib ( RECENTIN; AZD2171) is an inhibitor of VEGF signaling that has been shown in experimental models to prevent VEGF - A - induced angiogenesis and primary tumor growth, yet the effects of cediranib on VEGF receptor ( VEGFR) - 3 - mediated endothelial cell function and lymphangiogenesis are unknown.	Cediranib,0,9,Chemical	RECENTIN,12,20,Chemical	AZD2171,22,29,Chemical	VEGF,50,54,Gene_or_gene_product	VEGF - A,119,127,Gene_or_gene_product	tumor,163,168,Cancer	cediranib,196,205,Chemical	endothelial cell,247,263,Cell	"[{""token"": ""Cediranib"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical""}, {""token"": ""RECENTIN"", ""start_span"": 12, ""end_span"": 20, ""type"": ""Chemical""}, {""token"": ""AZD2171"", ""start_span"": 22, ""end_span"": 29, ""type"": ""Chemical""}, {""token"": ""VEGF"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - A"", ""start_span"": 119, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 163, ""end_span"": 168, ""type"": ""Cancer""}, {""token"": ""cediranib"", ""start_span"": 196, ""end_span"": 205, ""type"": ""Chemical""}, {""token"": ""endothelial cell"", ""start_span"": 247, ""end_span"": 263, ""type"": ""Cell""}]"	valid
Cediranib ( 6 mg / kg / day) also blocked angiogenesis and lymphangiogenesis induced by adenoviruses expressing VEGF - A or VEGF - C and compromised the blood and lymphatic vasculatures of VEGF - C - expressing tumors.	Cediranib,0,9,Chemical	adenoviruses,88,100,Organism	VEGF - A,112,120,Gene_or_gene_product	VEGF - C,124,132,Gene_or_gene_product	blood,153,158,Organism_substance	lymphatic vasculatures,163,185,Multi	VEGF - C,189,197,Gene_or_gene_product	tumors,211,217,Cancer	"[{""token"": ""Cediranib"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical""}, {""token"": ""adenoviruses"", ""start_span"": 88, ""end_span"": 100, ""type"": ""Organism""}, {""token"": ""VEGF - A"", ""start_span"": 112, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - C"", ""start_span"": 124, ""end_span"": 132, ""type"": ""Gene_or_gene_product""}, {""token"": ""blood"", ""start_span"": 153, ""end_span"": 158, ""type"": ""Organism_substance""}, {""token"": ""lymphatic vasculatures"", ""start_span"": 163, ""end_span"": 185, ""type"": ""Multi""}, {""token"": ""VEGF - C"", ""start_span"": 189, ""end_span"": 197, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 211, ""end_span"": 217, ""type"": ""Cancer""}]"	valid
Systemic administration of VEGF or LPS in adult mice resulted in cyclosporine A - sensitive reactivation of the DSCR1s promoter and endogenous gene expression in a subset of organs, including the heart and brain.	VEGF,27,31,Gene_or_gene_product	LPS,35,38,Chemical	mice,48,52,Organism	cyclosporine A,65,79,Chemical	DSCR1s,112,118,Gene_or_gene_product	organs,174,180,Organ	heart,196,201,Organ	brain,206,211,Organ	"[{""token"": ""VEGF"", ""start_span"": 27, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""LPS"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Chemical""}, {""token"": ""mice"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Organism""}, {""token"": ""cyclosporine A"", ""start_span"": 65, ""end_span"": 79, ""type"": ""Chemical""}, {""token"": ""DSCR1s"", ""start_span"": 112, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""organs"", ""start_span"": 174, ""end_span"": 180, ""type"": ""Organ""}, {""token"": ""heart"", ""start_span"": 196, ""end_span"": 201, ""type"": ""Organ""}, {""token"": ""brain"", ""start_span"": 206, ""end_span"": 211, ""type"": ""Organ""}]"	valid
Compared with CSC - low tumors, CSC - high tumors exhibited increased microvessel density and blood perfusion and induced increased mobilization and tumor recruitment of bone marrow - derived endothelial progenitor cells ( EPC).	CSC - low tumors,14,30,Cancer	CSC - high tumors,32,49,Cancer	microvessel,70,81,Tissue	blood,94,99,Organism_substance	tumor,149,154,Cancer	bone marrow,170,181,Multi	endothelial progenitor cells,192,220,Cell	EPC,223,226,Cell	"[{""token"": ""CSC - low tumors"", ""start_span"": 14, ""end_span"": 30, ""type"": ""Cancer""}, {""token"": ""CSC - high tumors"", ""start_span"": 32, ""end_span"": 49, ""type"": ""Cancer""}, {""token"": ""microvessel"", ""start_span"": 70, ""end_span"": 81, ""type"": ""Tissue""}, {""token"": ""blood"", ""start_span"": 94, ""end_span"": 99, ""type"": ""Organism_substance""}, {""token"": ""tumor"", ""start_span"": 149, ""end_span"": 154, ""type"": ""Cancer""}, {""token"": ""bone marrow"", ""start_span"": 170, ""end_span"": 181, ""type"": ""Multi""}, {""token"": ""endothelial progenitor cells"", ""start_span"": 192, ""end_span"": 220, ""type"": ""Cell""}, {""token"": ""EPC"", ""start_span"": 223, ""end_span"": 226, ""type"": ""Cell""}]"	valid
BPDE treatment caused induction of both AP - 1 and NF - kappaB activity as determined by luciferase reporter assay and only NF - kappaB induction in response to BPDE was significantly attenuated by TSC phenolic fraction whereas AP - 1 induction remains unaltered.	BPDE,0,4,Chemical	AP - 1,40,46,Gene_or_gene_product	NF - kappaB,51,62,Gene_or_gene_product	luciferase,89,99,Gene_or_gene_product	NF - kappaB,124,135,Gene_or_gene_product	BPDE,161,165,Chemical	TSC phenolic fraction,198,219,Chemical	AP - 1,228,234,Gene_or_gene_product	"[{""token"": ""BPDE"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Chemical""}, {""token"": ""AP - 1"", ""start_span"": 40, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 51, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""luciferase"", ""start_span"": 89, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 124, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}, {""token"": ""BPDE"", ""start_span"": 161, ""end_span"": 165, ""type"": ""Chemical""}, {""token"": ""TSC phenolic fraction"", ""start_span"": 198, ""end_span"": 219, ""type"": ""Chemical""}, {""token"": ""AP - 1"", ""start_span"": 228, ""end_span"": 234, ""type"": ""Gene_or_gene_product""}]"	valid
In this study, the aim was to investigate the effect of phenolic acids found abundantly in vegetables, i. e. gallic acid ( GA), caffeic acid ( CA) and protocatechuic acid ( PCA), on the inhibition of gastric adenocarcinoma ( AGS) cell metastasis.	phenolic acids,56,70,Chemical	vegetables,91,101,Organism_subdivision	gallic acid,109,120,Chemical	GA,123,125,Chemical	caffeic acid,128,140,Chemical	CA,143,145,Chemical	protocatechuic acid,151,170,Chemical	PCA,173,176,Chemical	"[{""token"": ""phenolic acids"", ""start_span"": 56, ""end_span"": 70, ""type"": ""Chemical""}, {""token"": ""vegetables"", ""start_span"": 91, ""end_span"": 101, ""type"": ""Organism_subdivision""}, {""token"": ""gallic acid"", ""start_span"": 109, ""end_span"": 120, ""type"": ""Chemical""}, {""token"": ""GA"", ""start_span"": 123, ""end_span"": 125, ""type"": ""Chemical""}, {""token"": ""caffeic acid"", ""start_span"": 128, ""end_span"": 140, ""type"": ""Chemical""}, {""token"": ""CA"", ""start_span"": 143, ""end_span"": 145, ""type"": ""Chemical""}, {""token"": ""protocatechuic acid"", ""start_span"": 151, ""end_span"": 170, ""type"": ""Chemical""}, {""token"": ""PCA"", ""start_span"": 173, ""end_span"": 176, ""type"": ""Chemical""}]"	valid
The quaternary benzo [ c] phenanthridine alkaloid sanguinarine inhibits the proliferation of cancerous cells from different origins, including lung, breast, pancreatic and colon, but nothing is known of its effects on osteosarcoma, a primary malignant bone tumour.	sanguinarine,50,62,Chemical	cancerous cells,93,108,Cell	lung,143,147,Organ	breast,149,155,Organism_subdivision	pancreatic,157,167,Organ	colon,172,177,Organ	osteosarcoma,218,230,Cancer	primary malignant bone tumour,234,263,Cancer	"[{""token"": ""sanguinarine"", ""start_span"": 50, ""end_span"": 62, ""type"": ""Chemical""}, {""token"": ""cancerous cells"", ""start_span"": 93, ""end_span"": 108, ""type"": ""Cell""}, {""token"": ""lung"", ""start_span"": 143, ""end_span"": 147, ""type"": ""Organ""}, {""token"": ""breast"", ""start_span"": 149, ""end_span"": 155, ""type"": ""Organism_subdivision""}, {""token"": ""pancreatic"", ""start_span"": 157, ""end_span"": 167, ""type"": ""Organ""}, {""token"": ""colon"", ""start_span"": 172, ""end_span"": 177, ""type"": ""Organ""}, {""token"": ""osteosarcoma"", ""start_span"": 218, ""end_span"": 230, ""type"": ""Cancer""}, {""token"": ""primary malignant bone tumour"", ""start_span"": 234, ""end_span"": 263, ""type"": ""Cancer""}]"	valid
The development and progression of colorectal cancer ( CRC) is a multi - step process, and the Wnt pathways with its two molecular gladiators adenomatous polyposis coli ( APC) and beta - catenin plays an important role in transforming a normal tissue into a malignant one.	colorectal cancer,35,52,Cancer	CRC,55,58,Cancer	Wnt,95,98,Gene_or_gene_product	adenomatous polyposis coli,142,168,Gene_or_gene_product	APC,171,174,Gene_or_gene_product	beta - catenin,180,194,Gene_or_gene_product	normal tissue,237,250,Tissue	malignant one,258,271,Cancer	"[{""token"": ""colorectal cancer"", ""start_span"": 35, ""end_span"": 52, ""type"": ""Cancer""}, {""token"": ""CRC"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Cancer""}, {""token"": ""Wnt"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""adenomatous polyposis coli"", ""start_span"": 142, ""end_span"": 168, ""type"": ""Gene_or_gene_product""}, {""token"": ""APC"", ""start_span"": 171, ""end_span"": 174, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta - catenin"", ""start_span"": 180, ""end_span"": 194, ""type"": ""Gene_or_gene_product""}, {""token"": ""normal tissue"", ""start_span"": 237, ""end_span"": 250, ""type"": ""Tissue""}, {""token"": ""malignant one"", ""start_span"": 258, ""end_span"": 271, ""type"": ""Cancer""}]"	valid
The results in steady state reveal that both substrates glucose and glutamine are continuously wasted by tumour cells, excreting two moles of lactate per mol of glucose and one mol of glutamate and ammonia per mol of glutamine consumed into the medium.	glucose,56,63,Chemical	glutamine,68,77,Amino_acid	tumour cells,105,117,Cell	lactate,142,149,Chemical	glucose,161,168,Chemical	glutamate,184,193,Amino_acid	ammonia,198,205,Chemical	glutamine,217,226,Amino_acid	"[{""token"": ""glucose"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Chemical""}, {""token"": ""glutamine"", ""start_span"": 68, ""end_span"": 77, ""type"": ""Amino_acid""}, {""token"": ""tumour cells"", ""start_span"": 105, ""end_span"": 117, ""type"": ""Cell""}, {""token"": ""lactate"", ""start_span"": 142, ""end_span"": 149, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 161, ""end_span"": 168, ""type"": ""Chemical""}, {""token"": ""glutamate"", ""start_span"": 184, ""end_span"": 193, ""type"": ""Amino_acid""}, {""token"": ""ammonia"", ""start_span"": 198, ""end_span"": 205, ""type"": ""Chemical""}, {""token"": ""glutamine"", ""start_span"": 217, ""end_span"": 226, ""type"": ""Amino_acid""}]"	valid
The amplification and overexpression of the HER - 2 / neu proto - oncogene, which encodes the tyrosine kinase receptor p185neu, have been observed frequently in tumors from human breast cancer patients and are correlated with poor prognosis.	HER - 2,44,51,Gene_or_gene_product	neu,54,57,Gene_or_gene_product	tyrosine,94,102,Amino_acid	p185neu,119,126,Gene_or_gene_product	tumors,161,167,Cancer	human,173,178,Organism	breast cancer,179,192,Cancer	patients,193,201,Organism	"[{""token"": ""HER - 2"", ""start_span"": 44, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""neu"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""tyrosine"", ""start_span"": 94, ""end_span"": 102, ""type"": ""Amino_acid""}, {""token"": ""p185neu"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 161, ""end_span"": 167, ""type"": ""Cancer""}, {""token"": ""human"", ""start_span"": 173, ""end_span"": 178, ""type"": ""Organism""}, {""token"": ""breast cancer"", ""start_span"": 179, ""end_span"": 192, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 193, ""end_span"": 201, ""type"": ""Organism""}]"	valid
Emodin also induced differentiation of HER - 2 / neu - overexpressing breast cancer cells by exhibiting a morphological maturation property of large lacy nuclei surrounded by sizable flat cytoplasm and by showing a measurable production of large lipid droplets, which is a marker of mature breast cells.	Emodin,0,6,Chemical	HER - 2,39,46,Gene_or_gene_product	neu,49,52,Gene_or_gene_product	breast cancer cells,70,89,Cell	nuclei,154,160,Cellular_component	flat cytoplasm,183,197,Organism_substance	lipid,246,251,Chemical	mature breast cells,283,302,Cell	"[{""token"": ""Emodin"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Chemical""}, {""token"": ""HER - 2"", ""start_span"": 39, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""neu"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancer cells"", ""start_span"": 70, ""end_span"": 89, ""type"": ""Cell""}, {""token"": ""nuclei"", ""start_span"": 154, ""end_span"": 160, ""type"": ""Cellular_component""}, {""token"": ""flat cytoplasm"", ""start_span"": 183, ""end_span"": 197, ""type"": ""Organism_substance""}, {""token"": ""lipid"", ""start_span"": 246, ""end_span"": 251, ""type"": ""Chemical""}, {""token"": ""mature breast cells"", ""start_span"": 283, ""end_span"": 302, ""type"": ""Cell""}]"	valid
The epidermal growth factor receptor ( EGF - R, c - erbB1), Her - 2 / neu ( c - erbB2), and c - erbB3 are members of the erbB - family.	epidermal growth factor receptor,4,36,Gene_or_gene_product	EGF - R,39,46,Gene_or_gene_product	c - erbB1,48,57,Gene_or_gene_product	Her - 2,60,67,Gene_or_gene_product	neu,70,73,Gene_or_gene_product	c - erbB2,76,85,Gene_or_gene_product	c - erbB3,92,101,Gene_or_gene_product	erbB,121,125,Gene_or_gene_product	"[{""token"": ""epidermal growth factor receptor"", ""start_span"": 4, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""EGF - R"", ""start_span"": 39, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - erbB1"", ""start_span"": 48, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""Her - 2"", ""start_span"": 60, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""neu"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - erbB2"", ""start_span"": 76, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""c - erbB3"", ""start_span"": 92, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""erbB"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}]"	valid
Since the vessels of normal non - neoplastic human tissues, e. g. of intestine or lymphatic organs, have few somatostatin receptors, the increased somatostatin receptor expression in peritumoral vessels observed in this study may be linked to the neoplastic process itself.	vessels,10,17,Multi	human,45,50,Organism	tissues,51,58,Tissue	intestine,69,78,Organ	lymphatic organs,82,98,Organ	somatostatin receptors,109,131,Gene_or_gene_product	somatostatin receptor,147,168,Gene_or_gene_product	peritumoral vessels,183,202,Multi	"[{""token"": ""vessels"", ""start_span"": 10, ""end_span"": 17, ""type"": ""Multi""}, {""token"": ""human"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Organism""}, {""token"": ""tissues"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Tissue""}, {""token"": ""intestine"", ""start_span"": 69, ""end_span"": 78, ""type"": ""Organ""}, {""token"": ""lymphatic organs"", ""start_span"": 82, ""end_span"": 98, ""type"": ""Organ""}, {""token"": ""somatostatin receptors"", ""start_span"": 109, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}, {""token"": ""somatostatin receptor"", ""start_span"": 147, ""end_span"": 168, ""type"": ""Gene_or_gene_product""}, {""token"": ""peritumoral vessels"", ""start_span"": 183, ""end_span"": 202, ""type"": ""Multi""}]"	valid
Syndecan - 1 is a cell surface proteoglycan that has been implicated in a number of cellular functions including cell - cell adhesion, cell - matrix anchorage and growth factor presentation for signalling receptors.	Syndecan - 1,0,12,Gene_or_gene_product	cell surface,18,30,Cellular_component	cellular,84,92,Cell	cell,113,117,Cell	cell,120,124,Cell	cell,135,139,Cell	matrix,142,148,Cellular_component	growth factor,163,176,Gene_or_gene_product	"[{""token"": ""Syndecan - 1"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell surface"", ""start_span"": 18, ""end_span"": 30, ""type"": ""Cellular_component""}, {""token"": ""cellular"", ""start_span"": 84, ""end_span"": 92, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 120, ""end_span"": 124, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Cell""}, {""token"": ""matrix"", ""start_span"": 142, ""end_span"": 148, ""type"": ""Cellular_component""}, {""token"": ""growth factor"", ""start_span"": 163, ""end_span"": 176, ""type"": ""Gene_or_gene_product""}]"	valid
In transfected MDCK canine kidney epithelial cells, 5T4 over - expression also results in increased motility, but disruption of cell - cell contacts, either by culturing cells in low calcium medium or by addition of HGF / SF, is needed.	MDCK canine kidney epithelial cells,15,50,Cell	5T4,52,55,Gene_or_gene_product	cell,128,132,Cell	cell,135,139,Cell	cells,170,175,Cell	calcium,183,190,Chemical	HGF,216,219,Gene_or_gene_product	SF,222,224,Gene_or_gene_product	"[{""token"": ""MDCK canine kidney epithelial cells"", ""start_span"": 15, ""end_span"": 50, ""type"": ""Cell""}, {""token"": ""5T4"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 128, ""end_span"": 132, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 170, ""end_span"": 175, ""type"": ""Cell""}, {""token"": ""calcium"", ""start_span"": 183, ""end_span"": 190, ""type"": ""Chemical""}, {""token"": ""HGF"", ""start_span"": 216, ""end_span"": 219, ""type"": ""Gene_or_gene_product""}, {""token"": ""SF"", ""start_span"": 222, ""end_span"": 224, ""type"": ""Gene_or_gene_product""}]"	valid
Focal adhesion kinase ( pp125FAK or FAK) is a protein tyrosine kinase which is associated with intracellular signalling cascades which are initiated when the integrin family of cell adhesion molecules engage extracellular matrix molecules.	Focal adhesion kinase,0,21,Gene_or_gene_product	pp125FAK,24,32,Gene_or_gene_product	FAK,36,39,Gene_or_gene_product	protein tyrosine kinase,46,69,Gene_or_gene_product	intracellular,95,108,Immaterial_anatomical_entity	integrin,158,166,Gene_or_gene_product	cell adhesion molecules,177,200,Gene_or_gene_product	extracellular matrix,208,228,Cellular_component	"[{""token"": ""Focal adhesion kinase"", ""start_span"": 0, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""pp125FAK"", ""start_span"": 24, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""FAK"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""protein tyrosine kinase"", ""start_span"": 46, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""intracellular"", ""start_span"": 95, ""end_span"": 108, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""integrin"", ""start_span"": 158, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell adhesion molecules"", ""start_span"": 177, ""end_span"": 200, ""type"": ""Gene_or_gene_product""}, {""token"": ""extracellular matrix"", ""start_span"": 208, ""end_span"": 228, ""type"": ""Cellular_component""}]"	valid
To investigate the significance of the C - terminal Abl actin - binding domain within Bcr / Abl p190 in the development of leukemia / lymphoma in vivo, mutant p190 DNA constructs were used to generate transgenic mice.	Abl,52,55,Gene_or_gene_product	actin,56,61,Gene_or_gene_product	Bcr / Abl p190,86,100,Gene_or_gene_product	leukemia,123,131,Cancer	lymphoma,134,142,Cancer	p190,159,163,Gene_or_gene_product	DNA,164,167,Cellular_component	transgenic mice,201,216,Organism	"[{""token"": ""Abl"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""actin"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcr / Abl p190"", ""start_span"": 86, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""leukemia"", ""start_span"": 123, ""end_span"": 131, ""type"": ""Cancer""}, {""token"": ""lymphoma"", ""start_span"": 134, ""end_span"": 142, ""type"": ""Cancer""}, {""token"": ""p190"", ""start_span"": 159, ""end_span"": 163, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 164, ""end_span"": 167, ""type"": ""Cellular_component""}, {""token"": ""transgenic mice"", ""start_span"": 201, ""end_span"": 216, ""type"": ""Organism""}]"	test
Western blot analysis of involved hematologic tissues of the p190 del C transgenics with end - stage disease showed high - level expression of the transgene and tyrosine phosphorylation of Cbl and Hef1 / Cas, proteins previously shown to be affected by Bcr / Abl.	hematologic tissues,34,53,Tissue	p190,61,65,Gene_or_gene_product	transgenics,72,83,Organism	tyrosine,161,169,Amino_acid	Cbl,189,192,Gene_or_gene_product	Hef1,197,201,Gene_or_gene_product	Cas,204,207,Gene_or_gene_product	Bcr / Abl,253,262,Gene_or_gene_product	"[{""token"": ""hematologic tissues"", ""start_span"": 34, ""end_span"": 53, ""type"": ""Tissue""}, {""token"": ""p190"", ""start_span"": 61, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""transgenics"", ""start_span"": 72, ""end_span"": 83, ""type"": ""Organism""}, {""token"": ""tyrosine"", ""start_span"": 161, ""end_span"": 169, ""type"": ""Amino_acid""}, {""token"": ""Cbl"", ""start_span"": 189, ""end_span"": 192, ""type"": ""Gene_or_gene_product""}, {""token"": ""Hef1"", ""start_span"": 197, ""end_span"": 201, ""type"": ""Gene_or_gene_product""}, {""token"": ""Cas"", ""start_span"": 204, ""end_span"": 207, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcr / Abl"", ""start_span"": 253, ""end_span"": 262, ""type"": ""Gene_or_gene_product""}]"	test
The results showed that expression levels of both nm23 - H1 and nm23 - H2 mRNA varied in normal buccal mucosa, leukoplakia, adjacent nontumorous mucosa, submandibular gland, CBM and lymph nodes with or without metastasis.	nm23 - H1,50,59,Gene_or_gene_product	nm23 - H2,64,73,Gene_or_gene_product	buccal mucosa,96,109,Multi	leukoplakia,111,122,Pathological_formation	nontumorous mucosa,133,151,Multi	submandibular gland,153,172,Organ	CBM,174,177,Cancer	lymph nodes,182,193,Multi	"[{""token"": ""nm23 - H1"", ""start_span"": 50, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""nm23 - H2"", ""start_span"": 64, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""buccal mucosa"", ""start_span"": 96, ""end_span"": 109, ""type"": ""Multi""}, {""token"": ""leukoplakia"", ""start_span"": 111, ""end_span"": 122, ""type"": ""Pathological_formation""}, {""token"": ""nontumorous mucosa"", ""start_span"": 133, ""end_span"": 151, ""type"": ""Multi""}, {""token"": ""submandibular gland"", ""start_span"": 153, ""end_span"": 172, ""type"": ""Organ""}, {""token"": ""CBM"", ""start_span"": 174, ""end_span"": 177, ""type"": ""Cancer""}, {""token"": ""lymph nodes"", ""start_span"": 182, ""end_span"": 193, ""type"": ""Multi""}]"	test
The similarity between RhoA effects and thyroid transformation by Ras suggests that RhoA may act as a downstream effector of Ras; in fact, the dominant negative RhoA N19 abolished the down - regulatory effect of Ras V12 over the Tg promoter.	RhoA,23,27,Gene_or_gene_product	thyroid,40,47,Cell	Ras,66,69,Gene_or_gene_product	RhoA,84,88,Gene_or_gene_product	Ras,125,128,Gene_or_gene_product	RhoA,161,165,Gene_or_gene_product	Ras,212,215,Gene_or_gene_product	Tg,229,231,Gene_or_gene_product	"[{""token"": ""RhoA"", ""start_span"": 23, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""thyroid"", ""start_span"": 40, ""end_span"": 47, ""type"": ""Cell""}, {""token"": ""Ras"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""RhoA"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ras"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Gene_or_gene_product""}, {""token"": ""RhoA"", ""start_span"": 161, ""end_span"": 165, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ras"", ""start_span"": 212, ""end_span"": 215, ""type"": ""Gene_or_gene_product""}, {""token"": ""Tg"", ""start_span"": 229, ""end_span"": 231, ""type"": ""Gene_or_gene_product""}]"	test
METHODS: The authors evaluated plasma endostatin ( PE) levels using an enzyme linked immunoassay in 71 patients with acute myeloid leukemia ( AML) and 43 patients with myelodysplastic syndrome ( MDS), and correlated PE with various clinical parameters.	plasma,31,37,Organism_substance	endostatin,38,48,Gene_or_gene_product	PE,51,53,Gene_or_gene_product	patients,103,111,Organism	acute myeloid leukemia,117,139,Cancer	AML,142,145,Cancer	patients,154,162,Organism	PE,216,218,Gene_or_gene_product	"[{""token"": ""plasma"", ""start_span"": 31, ""end_span"": 37, ""type"": ""Organism_substance""}, {""token"": ""endostatin"", ""start_span"": 38, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""PE"", ""start_span"": 51, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 103, ""end_span"": 111, ""type"": ""Organism""}, {""token"": ""acute myeloid leukemia"", ""start_span"": 117, ""end_span"": 139, ""type"": ""Cancer""}, {""token"": ""AML"", ""start_span"": 142, ""end_span"": 145, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 154, ""end_span"": 162, ""type"": ""Organism""}, {""token"": ""PE"", ""start_span"": 216, ""end_span"": 218, ""type"": ""Gene_or_gene_product""}]"	test
TS - 1 is a new, oral anticancer agent composed of two modulators, gimeracil ( CDHP) and oteracil potassium ( Oxo) are mixed with tegafur in a ratio of 1: 0. 4: 1.	TS - 1,0,6,Chemical	oral,17,21,Organism_subdivision	anticancer,22,32,Cancer	gimeracil,67,76,Chemical	CDHP,79,83,Chemical	oteracil potassium,89,107,Chemical	Oxo,110,113,Chemical	tegafur,130,137,Chemical	"[{""token"": ""TS - 1"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Chemical""}, {""token"": ""oral"", ""start_span"": 17, ""end_span"": 21, ""type"": ""Organism_subdivision""}, {""token"": ""anticancer"", ""start_span"": 22, ""end_span"": 32, ""type"": ""Cancer""}, {""token"": ""gimeracil"", ""start_span"": 67, ""end_span"": 76, ""type"": ""Chemical""}, {""token"": ""CDHP"", ""start_span"": 79, ""end_span"": 83, ""type"": ""Chemical""}, {""token"": ""oteracil potassium"", ""start_span"": 89, ""end_span"": 107, ""type"": ""Chemical""}, {""token"": ""Oxo"", ""start_span"": 110, ""end_span"": 113, ""type"": ""Chemical""}, {""token"": ""tegafur"", ""start_span"": 130, ""end_span"": 137, ""type"": ""Chemical""}]"	test
Exposure of SKOV - 3 cells to paclitaxel or carboplatin along with 317615 2HCl resulted in cell survivals that reflected additivity of 317615 x 2HCl with paclitaxel and greater - than - additive cytotoxicity with carboplatin.	SKOV - 3 cells,12,26,Cell	paclitaxel,30,40,Chemical	carboplatin,44,55,Chemical	317615 2HCl,67,78,Chemical	cell,91,95,Cell	317615 x 2HCl,135,148,Chemical	paclitaxel,154,164,Chemical	carboplatin,213,224,Chemical	"[{""token"": ""SKOV - 3 cells"", ""start_span"": 12, ""end_span"": 26, ""type"": ""Cell""}, {""token"": ""paclitaxel"", ""start_span"": 30, ""end_span"": 40, ""type"": ""Chemical""}, {""token"": ""carboplatin"", ""start_span"": 44, ""end_span"": 55, ""type"": ""Chemical""}, {""token"": ""317615 2HCl"", ""start_span"": 67, ""end_span"": 78, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Cell""}, {""token"": ""317615 x 2HCl"", ""start_span"": 135, ""end_span"": 148, ""type"": ""Chemical""}, {""token"": ""paclitaxel"", ""start_span"": 154, ""end_span"": 164, ""type"": ""Chemical""}, {""token"": ""carboplatin"", ""start_span"": 213, ""end_span"": 224, ""type"": ""Chemical""}]"	test
However, re - expression of wt - p53 in EU - 4 cells could restore the doxorubicin - p53 - survivin pathway, resulting in significantly decreased survivin expression and increased apoptosis in these cells after doxorubicin treatment.	p53,33,36,Gene_or_gene_product	EU - 4 cells,40,52,Cell	doxorubicin,71,82,Chemical	p53,85,88,Gene_or_gene_product	survivin,91,99,Gene_or_gene_product	survivin,146,154,Gene_or_gene_product	cells,199,204,Cell	doxorubicin,211,222,Chemical	"[{""token"": ""p53"", ""start_span"": 33, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""EU - 4 cells"", ""start_span"": 40, ""end_span"": 52, ""type"": ""Cell""}, {""token"": ""doxorubicin"", ""start_span"": 71, ""end_span"": 82, ""type"": ""Chemical""}, {""token"": ""p53"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""survivin"", ""start_span"": 91, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""survivin"", ""start_span"": 146, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 199, ""end_span"": 204, ""type"": ""Cell""}, {""token"": ""doxorubicin"", ""start_span"": 211, ""end_span"": 222, ""type"": ""Chemical""}]"	test
These data provide the first demonstration of IGF - I / II expression in the human lung in early gestation and indicate that the IGF family of growth factors, acting through the IGF - IR, is required as a survival factor during normal human lung vascularization.	IGF - I,46,53,Gene_or_gene_product	II,56,58,Gene_or_gene_product	human,77,82,Organism	lung,83,87,Organ	IGF,129,132,Gene_or_gene_product	IGF - IR,178,186,Gene_or_gene_product	human,235,240,Organism	lung,241,245,Organ	"[{""token"": ""IGF - I"", ""start_span"": 46, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""II"", ""start_span"": 56, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 77, ""end_span"": 82, ""type"": ""Organism""}, {""token"": ""lung"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Organ""}, {""token"": ""IGF"", ""start_span"": 129, ""end_span"": 132, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGF - IR"", ""start_span"": 178, ""end_span"": 186, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 235, ""end_span"": 240, ""type"": ""Organism""}, {""token"": ""lung"", ""start_span"": 241, ""end_span"": 245, ""type"": ""Organ""}]"	test
The tumour suppressor p53 and interferon - alpha and - beta ( IFN - alpha / beta) are essential for the induction of apoptosis in cancerous cells and in antiviral immune responses, respectively, but little is known about their interrelationship.	tumour,4,10,Cancer	p53,22,25,Gene_or_gene_product	interferon - alpha,30,48,Gene_or_gene_product	- beta,53,59,Gene_or_gene_product	IFN - alpha,62,73,Gene_or_gene_product	beta,76,80,Gene_or_gene_product	cancerous cells,130,145,Cell	antiviral,153,162,Organism	"[{""token"": ""tumour"", ""start_span"": 4, ""end_span"": 10, ""type"": ""Cancer""}, {""token"": ""p53"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""interferon - alpha"", ""start_span"": 30, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""- beta"", ""start_span"": 53, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""IFN - alpha"", ""start_span"": 62, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancerous cells"", ""start_span"": 130, ""end_span"": 145, ""type"": ""Cell""}, {""token"": ""antiviral"", ""start_span"": 153, ""end_span"": 162, ""type"": ""Organism""}]"	test
Herein, we report that these compounds effectively inhibited SDF - 1 - induced migration of human breast cancer cells ( MDA - MB - 231), human leukemia T cells ( Sup - T1) and human umbilical vein endothelial cells at concentrations of 10 - 100 nM in vitro.	SDF - 1,61,68,Gene_or_gene_product	human,92,97,Organism	breast cancer cells,98,117,Cell	MDA - MB - 231,120,134,Cell	human,137,142,Organism	leukemia T cells,143,159,Cell	Sup - T1,162,170,Cell	human umbilical vein endothelial cells,176,214,Cell	"[{""token"": ""SDF - 1"", ""start_span"": 61, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Organism""}, {""token"": ""breast cancer cells"", ""start_span"": 98, ""end_span"": 117, ""type"": ""Cell""}, {""token"": ""MDA - MB - 231"", ""start_span"": 120, ""end_span"": 134, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 137, ""end_span"": 142, ""type"": ""Organism""}, {""token"": ""leukemia T cells"", ""start_span"": 143, ""end_span"": 159, ""type"": ""Cell""}, {""token"": ""Sup - T1"", ""start_span"": 162, ""end_span"": 170, ""type"": ""Cell""}, {""token"": ""human umbilical vein endothelial cells"", ""start_span"": 176, ""end_span"": 214, ""type"": ""Cell""}]"	test
In the present study, we applied the alginate implant angiogenesis model in mice with normal ANG II levels, elevated ANG II levels by transgenic overexpression of angiotensinogen ( AOGEN), or in AT2 receptor - deficient mice.	alginate,37,45,Chemical	mice,76,80,Organism	ANG II,93,99,Gene_or_gene_product	ANG II,117,123,Gene_or_gene_product	angiotensinogen,163,178,Gene_or_gene_product	AOGEN,181,186,Gene_or_gene_product	AT2 receptor,195,207,Gene_or_gene_product	mice,220,224,Organism	"[{""token"": ""alginate"", ""start_span"": 37, ""end_span"": 45, ""type"": ""Chemical""}, {""token"": ""mice"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Organism""}, {""token"": ""ANG II"", ""start_span"": 93, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""ANG II"", ""start_span"": 117, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}, {""token"": ""angiotensinogen"", ""start_span"": 163, ""end_span"": 178, ""type"": ""Gene_or_gene_product""}, {""token"": ""AOGEN"", ""start_span"": 181, ""end_span"": 186, ""type"": ""Gene_or_gene_product""}, {""token"": ""AT2 receptor"", ""start_span"": 195, ""end_span"": 207, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 220, ""end_span"": 224, ""type"": ""Organism""}]"	test
We demonstrate that a decrease in the amount of circulating ANG II by the angiotensin - converting enzyme ( ACE) inhibitor enalapril or the AT1 receptor antagonist losartan induced a stimulation of in vivo angiogenesis implying an inhibitory function of ANG II through the AT1 receptor.	ANG II,60,66,Gene_or_gene_product	angiotensin - converting enzyme,74,105,Gene_or_gene_product	ACE,108,111,Gene_or_gene_product	enalapril,123,132,Chemical	AT1 receptor,140,152,Gene_or_gene_product	losartan,164,172,Chemical	ANG II,254,260,Gene_or_gene_product	AT1 receptor,273,285,Gene_or_gene_product	"[{""token"": ""ANG II"", ""start_span"": 60, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""angiotensin - converting enzyme"", ""start_span"": 74, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""ACE"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Gene_or_gene_product""}, {""token"": ""enalapril"", ""start_span"": 123, ""end_span"": 132, ""type"": ""Chemical""}, {""token"": ""AT1 receptor"", ""start_span"": 140, ""end_span"": 152, ""type"": ""Gene_or_gene_product""}, {""token"": ""losartan"", ""start_span"": 164, ""end_span"": 172, ""type"": ""Chemical""}, {""token"": ""ANG II"", ""start_span"": 254, ""end_span"": 260, ""type"": ""Gene_or_gene_product""}, {""token"": ""AT1 receptor"", ""start_span"": 273, ""end_span"": 285, ""type"": ""Gene_or_gene_product""}]"	test
Considering also that clusterin is downregulated during prostate cancer onset and progression, and that its upregulation has inhibited DNA synthesis and cell cycle progression of immortalized human prostate epithelial cells, we suggest that clusterin might be a new anti - oncogene in the prostate.	clusterin,22,31,Gene_or_gene_product	prostate cancer,56,71,Cancer	DNA,135,138,Cellular_component	cell,153,157,Cell	human,192,197,Organism	prostate epithelial cells,198,223,Cell	clusterin,241,250,Gene_or_gene_product	prostate,289,297,Organ	"[{""token"": ""clusterin"", ""start_span"": 22, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""prostate cancer"", ""start_span"": 56, ""end_span"": 71, ""type"": ""Cancer""}, {""token"": ""DNA"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Cellular_component""}, {""token"": ""cell"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 192, ""end_span"": 197, ""type"": ""Organism""}, {""token"": ""prostate epithelial cells"", ""start_span"": 198, ""end_span"": 223, ""type"": ""Cell""}, {""token"": ""clusterin"", ""start_span"": 241, ""end_span"": 250, ""type"": ""Gene_or_gene_product""}, {""token"": ""prostate"", ""start_span"": 289, ""end_span"": 297, ""type"": ""Organ""}]"	test
Here we demonstrate that bone marrow - derived haematopoietic progenitor cells that express vascular endothelial growth factor receptor 1 ( VEGFR1; also known as Flt1) home to tumour - specific pre - metastatic sites and form cellular clusters before the arrival of tumour cells.	bone marrow - derived haematopoietic progenitor cells,25,78,Cell	vascular endothelial growth factor receptor 1,92,137,Gene_or_gene_product	VEGFR1,140,146,Gene_or_gene_product	Flt1,162,166,Gene_or_gene_product	tumour,176,182,Cancer	sites,211,216,Multi	cellular clusters,226,243,Cell	tumour cells,266,278,Cell	"[{""token"": ""bone marrow - derived haematopoietic progenitor cells"", ""start_span"": 25, ""end_span"": 78, ""type"": ""Cell""}, {""token"": ""vascular endothelial growth factor receptor 1"", ""start_span"": 92, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR1"", ""start_span"": 140, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""Flt1"", ""start_span"": 162, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumour"", ""start_span"": 176, ""end_span"": 182, ""type"": ""Cancer""}, {""token"": ""sites"", ""start_span"": 211, ""end_span"": 216, ""type"": ""Multi""}, {""token"": ""cellular clusters"", ""start_span"": 226, ""end_span"": 243, ""type"": ""Cell""}, {""token"": ""tumour cells"", ""start_span"": 266, ""end_span"": 278, ""type"": ""Cell""}]"	test
We also show that VEGFR1 + cells express VLA - 4 ( also known as integrin alpha4beta1), and that tumour - specific growth factors upregulate fibronectin - - a VLA - 4 ligand - - in resident fibroblasts, providing a permissive niche for incoming tumour cells.	VEGFR1,18,24,Gene_or_gene_product	VLA - 4,41,48,Gene_or_gene_product	integrin alpha4beta1,65,85,Gene_or_gene_product	tumour,97,103,Cancer	fibronectin,141,152,Gene_or_gene_product	VLA - 4,159,166,Gene_or_gene_product	fibroblasts,190,201,Cell	tumour cells,245,257,Cell	"[{""token"": ""VEGFR1"", ""start_span"": 18, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""VLA - 4"", ""start_span"": 41, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""integrin alpha4beta1"", ""start_span"": 65, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumour"", ""start_span"": 97, ""end_span"": 103, ""type"": ""Cancer""}, {""token"": ""fibronectin"", ""start_span"": 141, ""end_span"": 152, ""type"": ""Gene_or_gene_product""}, {""token"": ""VLA - 4"", ""start_span"": 159, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibroblasts"", ""start_span"": 190, ""end_span"": 201, ""type"": ""Cell""}, {""token"": ""tumour cells"", ""start_span"": 245, ""end_span"": 257, ""type"": ""Cell""}]"	test
Because PIM - 1 is a STAT5 target gene, we analyzed the role of the family of PIM serine / threonine kinases ( PIM - 1 to PIM - 3) in PTK - mediated transformation of hematopoietic cells.	PIM - 1,8,15,Gene_or_gene_product	STAT5,21,26,Gene_or_gene_product	serine,82,88,Amino_acid	threonine,91,100,Amino_acid	PIM - 1,111,118,Gene_or_gene_product	PIM - 3,122,129,Gene_or_gene_product	PTK,134,137,Gene_or_gene_product	hematopoietic cells,167,186,Cell	"[{""token"": ""PIM - 1"", ""start_span"": 8, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""STAT5"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""serine"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Amino_acid""}, {""token"": ""threonine"", ""start_span"": 91, ""end_span"": 100, ""type"": ""Amino_acid""}, {""token"": ""PIM - 1"", ""start_span"": 111, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""PIM - 3"", ""start_span"": 122, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTK"", ""start_span"": 134, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}, {""token"": ""hematopoietic cells"", ""start_span"": 167, ""end_span"": 186, ""type"": ""Cell""}]"	test
Interestingly, cells transformed by FLT3 and BCR / ABL mutations that confer resistance to small - molecule tyrosine kinase inhibitors were still sensitive to knockdown of PIM - 2, or PIM - 1 and PIM - 2 by RNAi.	cells,15,20,Cell	FLT3,36,40,Gene_or_gene_product	BCR,45,48,Gene_or_gene_product	ABL,51,54,Gene_or_gene_product	small - molecule tyrosine kinase,91,123,Gene_or_gene_product	PIM - 2,172,179,Gene_or_gene_product	PIM - 1,184,191,Gene_or_gene_product	PIM - 2,196,203,Gene_or_gene_product	"[{""token"": ""cells"", ""start_span"": 15, ""end_span"": 20, ""type"": ""Cell""}, {""token"": ""FLT3"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Gene_or_gene_product""}, {""token"": ""BCR"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""ABL"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""small - molecule tyrosine kinase"", ""start_span"": 91, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}, {""token"": ""PIM - 2"", ""start_span"": 172, ""end_span"": 179, ""type"": ""Gene_or_gene_product""}, {""token"": ""PIM - 1"", ""start_span"": 184, ""end_span"": 191, ""type"": ""Gene_or_gene_product""}, {""token"": ""PIM - 2"", ""start_span"": 196, ""end_span"": 203, ""type"": ""Gene_or_gene_product""}]"	test
The caprine placenta is usually considered to have increased interhemal distance compared with endotheliochorial and hemochorial types: our results suggest that the very extensive development of sinusoids and crypts may compensate for any negative consequences of the placental architecture.	caprine,4,11,Organism	placenta,12,20,Organ	interhemal,61,71,Immaterial_anatomical_entity	endotheliochorial,95,112,Organ	hemochorial types,117,134,Organ	sinusoids,195,204,Tissue	crypts,209,215,Multi	placental,268,277,Organ	"[{""token"": ""caprine"", ""start_span"": 4, ""end_span"": 11, ""type"": ""Organism""}, {""token"": ""placenta"", ""start_span"": 12, ""end_span"": 20, ""type"": ""Organ""}, {""token"": ""interhemal"", ""start_span"": 61, ""end_span"": 71, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""endotheliochorial"", ""start_span"": 95, ""end_span"": 112, ""type"": ""Organ""}, {""token"": ""hemochorial types"", ""start_span"": 117, ""end_span"": 134, ""type"": ""Organ""}, {""token"": ""sinusoids"", ""start_span"": 195, ""end_span"": 204, ""type"": ""Tissue""}, {""token"": ""crypts"", ""start_span"": 209, ""end_span"": 215, ""type"": ""Multi""}, {""token"": ""placental"", ""start_span"": 268, ""end_span"": 277, ""type"": ""Organ""}]"	test
This analysis revealed a higher expression of vessel maturation and stabilisation factors ( placental growth factor, PDGFB1, angiopoietin 1) in CC - RCC with high MVD, a group of CC - RCC highly enriched in low nuclear grade CC - RCC, with low ECP%.	vessel,46,52,Multi	placental growth factor,92,115,Gene_or_gene_product	PDGFB1,117,123,Gene_or_gene_product	angiopoietin 1,125,139,Gene_or_gene_product	CC - RCC,144,152,Cancer	CC - RCC,179,187,Cancer	nuclear,211,218,Cellular_component	CC - RCC,225,233,Cancer	"[{""token"": ""vessel"", ""start_span"": 46, ""end_span"": 52, ""type"": ""Multi""}, {""token"": ""placental growth factor"", ""start_span"": 92, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""PDGFB1"", ""start_span"": 117, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}, {""token"": ""angiopoietin 1"", ""start_span"": 125, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}, {""token"": ""CC - RCC"", ""start_span"": 144, ""end_span"": 152, ""type"": ""Cancer""}, {""token"": ""CC - RCC"", ""start_span"": 179, ""end_span"": 187, ""type"": ""Cancer""}, {""token"": ""nuclear"", ""start_span"": 211, ""end_span"": 218, ""type"": ""Cellular_component""}, {""token"": ""CC - RCC"", ""start_span"": 225, ""end_span"": 233, ""type"": ""Cancer""}]"	test
In 1983, Harold Dvorak and his colleagues were the first to show that tumor cells secreted vascular permeability factor ( VPF) and that a blocking antibody to VPF could prevent the edema and fluid accumulation that is characteristic of human cancers.	tumor cells,70,81,Cell	vascular permeability factor,91,119,Gene_or_gene_product	VPF,122,125,Gene_or_gene_product	VPF,159,162,Gene_or_gene_product	edema,181,186,Pathological_formation	fluid,191,196,Organism_substance	human,236,241,Organism	cancers,242,249,Cancer	"[{""token"": ""tumor cells"", ""start_span"": 70, ""end_span"": 81, ""type"": ""Cell""}, {""token"": ""vascular permeability factor"", ""start_span"": 91, ""end_span"": 119, ""type"": ""Gene_or_gene_product""}, {""token"": ""VPF"", ""start_span"": 122, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""VPF"", ""start_span"": 159, ""end_span"": 162, ""type"": ""Gene_or_gene_product""}, {""token"": ""edema"", ""start_span"": 181, ""end_span"": 186, ""type"": ""Pathological_formation""}, {""token"": ""fluid"", ""start_span"": 191, ""end_span"": 196, ""type"": ""Organism_substance""}, {""token"": ""human"", ""start_span"": 236, ""end_span"": 241, ""type"": ""Organism""}, {""token"": ""cancers"", ""start_span"": 242, ""end_span"": 249, ""type"": ""Cancer""}]"	test
In the current study, Hedgehog signaling in tumor related vasculature and microenvironment was examined using human umbilical vein endothelial cells and B16F0 ( murine melanoma) tumors models.	Hedgehog,22,30,Gene_or_gene_product	tumor,44,49,Cancer	vasculature,58,69,Multi	human umbilical vein endothelial cells,110,148,Cell	B16F0,153,158,Cell	murine,161,167,Organism	melanoma,168,176,Cancer	tumors,178,184,Cancer	"[{""token"": ""Hedgehog"", ""start_span"": 22, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Cancer""}, {""token"": ""vasculature"", ""start_span"": 58, ""end_span"": 69, ""type"": ""Multi""}, {""token"": ""human umbilical vein endothelial cells"", ""start_span"": 110, ""end_span"": 148, ""type"": ""Cell""}, {""token"": ""B16F0"", ""start_span"": 153, ""end_span"": 158, ""type"": ""Cell""}, {""token"": ""murine"", ""start_span"": 161, ""end_span"": 167, ""type"": ""Organism""}, {""token"": ""melanoma"", ""start_span"": 168, ""end_span"": 176, ""type"": ""Cancer""}, {""token"": ""tumors"", ""start_span"": 178, ""end_span"": 184, ""type"": ""Cancer""}]"	test
Interestingly, CDK4 - expressing cells, but not CDK2 - expressing cells, strongly synergize with lack of p27 ( Kip1) to generate pituitary carcinomas that appear with shortened latency and are drastically more aggressive than those arising in p27 ( - / -) mice.	CDK4,15,19,Gene_or_gene_product	cells,33,38,Cell	CDK2,48,52,Gene_or_gene_product	cells,66,71,Cell	p27,105,108,Gene_or_gene_product	Kip1,111,115,Gene_or_gene_product	pituitary carcinomas,129,149,Cancer	p27,243,246,Gene_or_gene_product	"[{""token"": ""CDK4"", ""start_span"": 15, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Cell""}, {""token"": ""CDK2"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Cell""}, {""token"": ""p27"", ""start_span"": 105, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""Kip1"", ""start_span"": 111, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""pituitary carcinomas"", ""start_span"": 129, ""end_span"": 149, ""type"": ""Cancer""}, {""token"": ""p27"", ""start_span"": 243, ""end_span"": 246, ""type"": ""Gene_or_gene_product""}]"	test
Immunohistochemistry examinations in the human surgical specimens have shown that a downregulation of TSP - 1 during the progression of cervical carcinogenesis was accompanied by an emergence in the upregulation of stroma markers, alpha - smooth muscle actin ( alpha - SMA) and desmin.	human,41,46,Organism	surgical specimens,47,65,Cancer	TSP - 1,102,109,Gene_or_gene_product	cervical,136,144,Multi	stroma markers,215,229,Gene_or_gene_product	alpha - smooth muscle actin,231,258,Gene_or_gene_product	alpha - SMA,261,272,Gene_or_gene_product	desmin,278,284,Gene_or_gene_product	"[{""token"": ""human"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Organism""}, {""token"": ""surgical specimens"", ""start_span"": 47, ""end_span"": 65, ""type"": ""Cancer""}, {""token"": ""TSP - 1"", ""start_span"": 102, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""cervical"", ""start_span"": 136, ""end_span"": 144, ""type"": ""Multi""}, {""token"": ""stroma markers"", ""start_span"": 215, ""end_span"": 229, ""type"": ""Gene_or_gene_product""}, {""token"": ""alpha - smooth muscle actin"", ""start_span"": 231, ""end_span"": 258, ""type"": ""Gene_or_gene_product""}, {""token"": ""alpha - SMA"", ""start_span"": 261, ""end_span"": 272, ""type"": ""Gene_or_gene_product""}, {""token"": ""desmin"", ""start_span"": 278, ""end_span"": 284, ""type"": ""Gene_or_gene_product""}]"	test
PURPOSE: We prepared tumor endothelium targeted cRGD - modified heparin derivative ( cRGD - HL) by coupling heparin - lithocholic acid ( HL) with cRGDyK, and evaluated inhibition effects of cRGD - HL on angiogenesis and tumor growth.	tumor endothelium,21,38,Tissue	cRGD - modified heparin derivative,48,82,Chemical	cRGD - HL,85,94,Chemical	heparin - lithocholic acid,108,134,Chemical	HL,137,139,Chemical	cRGDyK,146,152,Chemical	cRGD - HL,190,199,Chemical	tumor,220,225,Cancer	"[{""token"": ""tumor endothelium"", ""start_span"": 21, ""end_span"": 38, ""type"": ""Tissue""}, {""token"": ""cRGD - modified heparin derivative"", ""start_span"": 48, ""end_span"": 82, ""type"": ""Chemical""}, {""token"": ""cRGD - HL"", ""start_span"": 85, ""end_span"": 94, ""type"": ""Chemical""}, {""token"": ""heparin - lithocholic acid"", ""start_span"": 108, ""end_span"": 134, ""type"": ""Chemical""}, {""token"": ""HL"", ""start_span"": 137, ""end_span"": 139, ""type"": ""Chemical""}, {""token"": ""cRGDyK"", ""start_span"": 146, ""end_span"": 152, ""type"": ""Chemical""}, {""token"": ""cRGD - HL"", ""start_span"": 190, ""end_span"": 199, ""type"": ""Chemical""}, {""token"": ""tumor"", ""start_span"": 220, ""end_span"": 225, ""type"": ""Cancer""}]"	test
The cell autonomous function of p53 in melanocytes is not well described, however, the balance of the evidence suggests that p53 is an effective tumor suppressor and the myriad of mechanisms by which the p53 pathway may be dysregulated in tumors attests to it importance as a tumor suppressor.	cell,4,8,Cell	p53,32,35,Gene_or_gene_product	melanocytes,39,50,Cell	p53,125,128,Gene_or_gene_product	tumor,145,150,Cancer	p53,204,207,Gene_or_gene_product	tumors,239,245,Cancer	tumor,276,281,Cancer	"[{""token"": ""cell"", ""start_span"": 4, ""end_span"": 8, ""type"": ""Cell""}, {""token"": ""p53"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""melanocytes"", ""start_span"": 39, ""end_span"": 50, ""type"": ""Cell""}, {""token"": ""p53"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 145, ""end_span"": 150, ""type"": ""Cancer""}, {""token"": ""p53"", ""start_span"": 204, ""end_span"": 207, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 239, ""end_span"": 245, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 276, ""end_span"": 281, ""type"": ""Cancer""}]"	test
Oxygen consumption of HepG2 cells supported by either pyruvate / malate or succinate was inhibited when cells were pre - incubated with 3 - BrPA in glucose - free medium.	Oxygen,0,6,Chemical	HepG2 cells,22,33,Cell	pyruvate,54,62,Chemical	malate,65,71,Chemical	succinate,75,84,Chemical	cells,104,109,Cell	3 - BrPA,136,144,Chemical	glucose,148,155,Chemical	"[{""token"": ""Oxygen"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Chemical""}, {""token"": ""HepG2 cells"", ""start_span"": 22, ""end_span"": 33, ""type"": ""Cell""}, {""token"": ""pyruvate"", ""start_span"": 54, ""end_span"": 62, ""type"": ""Chemical""}, {""token"": ""malate"", ""start_span"": 65, ""end_span"": 71, ""type"": ""Chemical""}, {""token"": ""succinate"", ""start_span"": 75, ""end_span"": 84, ""type"": ""Chemical""}, {""token"": ""cells"", ""start_span"": 104, ""end_span"": 109, ""type"": ""Cell""}, {""token"": ""3 - BrPA"", ""start_span"": 136, ""end_span"": 144, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 148, ""end_span"": 155, ""type"": ""Chemical""}]"	test
An increase in oligomycin - independent respiration was observed in HepG2 cells treated with 3 - BrPA only when incubated in glucose - supplemented medium, indicating that 3 - BrPA induces mitochondrial proton leakage as well as blocking the electron transport system.	oligomycin,15,25,Chemical	HepG2 cells,68,79,Cell	3 - BrPA,93,101,Chemical	glucose,125,132,Chemical	3 - BrPA,172,180,Chemical	mitochondrial,189,202,Cellular_component	proton,203,209,Chemical	electron,242,250,Chemical	"[{""token"": ""oligomycin"", ""start_span"": 15, ""end_span"": 25, ""type"": ""Chemical""}, {""token"": ""HepG2 cells"", ""start_span"": 68, ""end_span"": 79, ""type"": ""Cell""}, {""token"": ""3 - BrPA"", ""start_span"": 93, ""end_span"": 101, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 125, ""end_span"": 132, ""type"": ""Chemical""}, {""token"": ""3 - BrPA"", ""start_span"": 172, ""end_span"": 180, ""type"": ""Chemical""}, {""token"": ""mitochondrial"", ""start_span"": 189, ""end_span"": 202, ""type"": ""Cellular_component""}, {""token"": ""proton"", ""start_span"": 203, ""end_span"": 209, ""type"": ""Chemical""}, {""token"": ""electron"", ""start_span"": 242, ""end_span"": 250, ""type"": ""Chemical""}]"	test
All of these results indicate that Akt / mTOR - dependent translation of HIF - 1alpha plays a critical role in the postirradiation up - regulation of intratumoral HIF - 1 activity in response to radiation - induced alterations of glucose and oxygen availability in a solid tumor.	Akt,35,38,Gene_or_gene_product	mTOR,41,45,Gene_or_gene_product	HIF - 1alpha,73,85,Gene_or_gene_product	intratumoral,150,162,Cancer	HIF - 1,163,170,Gene_or_gene_product	glucose,230,237,Chemical	oxygen,242,248,Chemical	solid tumor,267,278,Cancer	"[{""token"": ""Akt"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""mTOR"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1alpha"", ""start_span"": 73, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""intratumoral"", ""start_span"": 150, ""end_span"": 162, ""type"": ""Cancer""}, {""token"": ""HIF - 1"", ""start_span"": 163, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}, {""token"": ""glucose"", ""start_span"": 230, ""end_span"": 237, ""type"": ""Chemical""}, {""token"": ""oxygen"", ""start_span"": 242, ""end_span"": 248, ""type"": ""Chemical""}, {""token"": ""solid tumor"", ""start_span"": 267, ""end_span"": 278, ""type"": ""Cancer""}]"	test
We used microdialysis to sample IL - 8 in normal human breast tissue in situ in pre - and postmenopausal women, preoperatively in breast cancers of women, and in experimental breast cancer in mice.	IL - 8,32,38,Gene_or_gene_product	human,49,54,Organism	breast tissue,55,68,Tissue	women,105,110,Organism	breast cancers,130,144,Cancer	women,148,153,Organism	breast cancer,175,188,Cancer	mice,192,196,Organism	"[{""token"": ""IL - 8"", ""start_span"": 32, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Organism""}, {""token"": ""breast tissue"", ""start_span"": 55, ""end_span"": 68, ""type"": ""Tissue""}, {""token"": ""women"", ""start_span"": 105, ""end_span"": 110, ""type"": ""Organism""}, {""token"": ""breast cancers"", ""start_span"": 130, ""end_span"": 144, ""type"": ""Cancer""}, {""token"": ""women"", ""start_span"": 148, ""end_span"": 153, ""type"": ""Organism""}, {""token"": ""breast cancer"", ""start_span"": 175, ""end_span"": 188, ""type"": ""Cancer""}, {""token"": ""mice"", ""start_span"": 192, ""end_span"": 196, ""type"": ""Organism""}]"	test
In experimental breast cancer, estradiol increased IL - 8 whereas the anti - estrogen tamoxifen inhibited the secretion of IL - 8 both in vitro and extracellularly in vivo in tumors of nude mice.	breast cancer,16,29,Cancer	estradiol,31,40,Chemical	IL - 8,51,57,Gene_or_gene_product	estrogen,77,85,Chemical	tamoxifen,86,95,Chemical	IL - 8,123,129,Gene_or_gene_product	tumors,175,181,Cancer	nude mice,185,194,Organism	"[{""token"": ""breast cancer"", ""start_span"": 16, ""end_span"": 29, ""type"": ""Cancer""}, {""token"": ""estradiol"", ""start_span"": 31, ""end_span"": 40, ""type"": ""Chemical""}, {""token"": ""IL - 8"", ""start_span"": 51, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""estrogen"", ""start_span"": 77, ""end_span"": 85, ""type"": ""Chemical""}, {""token"": ""tamoxifen"", ""start_span"": 86, ""end_span"": 95, ""type"": ""Chemical""}, {""token"": ""IL - 8"", ""start_span"": 123, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 175, ""end_span"": 181, ""type"": ""Cancer""}, {""token"": ""nude mice"", ""start_span"": 185, ""end_span"": 194, ""type"": ""Organism""}]"	test
Exposure of wild - type primary mouse cerebral endothelial cells to the CD47 ligand thrombospondin 1 ( TSP - 1) induced an increasing amount of cell death, whereas cytotoxicity was significantly decreased in cerebral endothelial cells derived from CD47 knockout mice.	mouse,32,37,Organism	cerebral endothelial cells,38,64,Cell	CD47,72,76,Gene_or_gene_product	thrombospondin 1,84,100,Gene_or_gene_product	TSP - 1,103,110,Gene_or_gene_product	cell,144,148,Cell	cerebral endothelial cells,208,234,Cell	CD47,248,252,Gene_or_gene_product	"[{""token"": ""mouse"", ""start_span"": 32, ""end_span"": 37, ""type"": ""Organism""}, {""token"": ""cerebral endothelial cells"", ""start_span"": 38, ""end_span"": 64, ""type"": ""Cell""}, {""token"": ""CD47"", ""start_span"": 72, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""thrombospondin 1"", ""start_span"": 84, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""TSP - 1"", ""start_span"": 103, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Cell""}, {""token"": ""cerebral endothelial cells"", ""start_span"": 208, ""end_span"": 234, ""type"": ""Cell""}, {""token"": ""CD47"", ""start_span"": 248, ""end_span"": 252, ""type"": ""Gene_or_gene_product""}]"	test
A putative progestin - response element was identified in the human TSP - 1 promoter, which is consistent with the hypothesis that a progestin - PR complex might directly regulate transcription of the TSP - 1 gene in human cells.	progestin,11,20,Chemical	human,62,67,Organism	TSP - 1,68,75,Gene_or_gene_product	progestin,133,142,Chemical	PR,145,147,Gene_or_gene_product	TSP - 1,201,208,Gene_or_gene_product	human,217,222,Organism	cells,223,228,Cell	"[{""token"": ""progestin"", ""start_span"": 11, ""end_span"": 20, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Organism""}, {""token"": ""TSP - 1"", ""start_span"": 68, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""progestin"", ""start_span"": 133, ""end_span"": 142, ""type"": ""Chemical""}, {""token"": ""PR"", ""start_span"": 145, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}, {""token"": ""TSP - 1"", ""start_span"": 201, ""end_span"": 208, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 217, ""end_span"": 222, ""type"": ""Organism""}, {""token"": ""cells"", ""start_span"": 223, ""end_span"": 228, ""type"": ""Cell""}]"	test
Furthermore, overexpression of TLX in Ink4a / Arf ( - / -) astrocytes inhibited cell migration and invasion and promoted neurosphere formation and Nestin expression, which are hallmark characteristics of glioma stem cells, under stem cell culture conditions.	TLX,31,34,Gene_or_gene_product	Ink4a,38,43,Gene_or_gene_product	Arf,46,49,Gene_or_gene_product	cell,80,84,Cell	neurosphere,121,132,Cell	Nestin,147,153,Gene_or_gene_product	glioma stem cells,204,221,Cell	stem cell,229,238,Cell	"[{""token"": ""TLX"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ink4a"", ""start_span"": 38, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""Arf"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 80, ""end_span"": 84, ""type"": ""Cell""}, {""token"": ""neurosphere"", ""start_span"": 121, ""end_span"": 132, ""type"": ""Cell""}, {""token"": ""Nestin"", ""start_span"": 147, ""end_span"": 153, ""type"": ""Gene_or_gene_product""}, {""token"": ""glioma stem cells"", ""start_span"": 204, ""end_span"": 221, ""type"": ""Cell""}, {""token"": ""stem cell"", ""start_span"": 229, ""end_span"": 238, ""type"": ""Cell""}]"	test
Adult mutants became sterile males due to the meiotic arrest of spermatocytes, which then died by apoptosis, followed by neoplastic proliferation of gonad somatic cells that was similar to neoplasia observed in ageing dead end ( dnd) - knockdown males, which lack germ cells.	Adult mutants,0,13,Organism	spermatocytes,64,77,Cell	neoplastic,121,131,Cancer	gonad somatic cells,149,168,Cell	neoplasia,189,198,Pathological_formation	dead end,218,226,Gene_or_gene_product	dnd,229,232,Gene_or_gene_product	germ cells,264,274,Cell	"[{""token"": ""Adult mutants"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Organism""}, {""token"": ""spermatocytes"", ""start_span"": 64, ""end_span"": 77, ""type"": ""Cell""}, {""token"": ""neoplastic"", ""start_span"": 121, ""end_span"": 131, ""type"": ""Cancer""}, {""token"": ""gonad somatic cells"", ""start_span"": 149, ""end_span"": 168, ""type"": ""Cell""}, {""token"": ""neoplasia"", ""start_span"": 189, ""end_span"": 198, ""type"": ""Pathological_formation""}, {""token"": ""dead end"", ""start_span"": 218, ""end_span"": 226, ""type"": ""Gene_or_gene_product""}, {""token"": ""dnd"", ""start_span"": 229, ""end_span"": 232, ""type"": ""Gene_or_gene_product""}, {""token"": ""germ cells"", ""start_span"": 264, ""end_span"": 274, ""type"": ""Cell""}]"	test
The expression of ARD1 was augmented by treatment with synthetic androgen ( R1881) unless AR is deficient or is inhibited by AR - specific siRNA or androgen inhibitor bicalutamide ( Casodex).	ARD1,18,22,Gene_or_gene_product	androgen,65,73,Chemical	R1881,76,81,Chemical	AR,90,92,Gene_or_gene_product	AR,125,127,Gene_or_gene_product	androgen,148,156,Chemical	bicalutamide,167,179,Chemical	Casodex,182,189,Chemical	"[{""token"": ""ARD1"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Gene_or_gene_product""}, {""token"": ""androgen"", ""start_span"": 65, ""end_span"": 73, ""type"": ""Chemical""}, {""token"": ""R1881"", ""start_span"": 76, ""end_span"": 81, ""type"": ""Chemical""}, {""token"": ""AR"", ""start_span"": 90, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""AR"", ""start_span"": 125, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}, {""token"": ""androgen"", ""start_span"": 148, ""end_span"": 156, ""type"": ""Chemical""}, {""token"": ""bicalutamide"", ""start_span"": 167, ""end_span"": 179, ""type"": ""Chemical""}, {""token"": ""Casodex"", ""start_span"": 182, ""end_span"": 189, ""type"": ""Chemical""}]"	test
The activity of type IV collagenase, which enables tumor cells to degrade collagen type IV found in the subendothelial basement membrane, has been correlated with the metastatic potential in several tumor types, including the rat 13762NF mammary adenocarcinoma cell line and its clones.	type IV collagenase,16,35,Gene_or_gene_product	tumor cells,51,62,Cell	collagen type IV,74,90,Gene_or_gene_product	subendothelial basement membrane,104,136,Cellular_component	tumor,199,204,Cancer	rat,226,229,Organism	13762NF mammary adenocarcinoma cell line,230,270,Cell	clones,279,285,Cell	"[{""token"": ""type IV collagenase"", ""start_span"": 16, ""end_span"": 35, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor cells"", ""start_span"": 51, ""end_span"": 62, ""type"": ""Cell""}, {""token"": ""collagen type IV"", ""start_span"": 74, ""end_span"": 90, ""type"": ""Gene_or_gene_product""}, {""token"": ""subendothelial basement membrane"", ""start_span"": 104, ""end_span"": 136, ""type"": ""Cellular_component""}, {""token"": ""tumor"", ""start_span"": 199, ""end_span"": 204, ""type"": ""Cancer""}, {""token"": ""rat"", ""start_span"": 226, ""end_span"": 229, ""type"": ""Organism""}, {""token"": ""13762NF mammary adenocarcinoma cell line"", ""start_span"": 230, ""end_span"": 270, ""type"": ""Cell""}, {""token"": ""clones"", ""start_span"": 279, ""end_span"": 285, ""type"": ""Cell""}]"	test
Cells of the highly metastatic lung - colonizing clone MTF7. T35. 3, derived from the 13762NF cell line, were treated for 3 days with 0. 1, 1, or 10 microM all - trans - RA, harvested, and seeded on [ 3H] proline - labeled extracellular matrix deposited by cultured rat lung endothelial cells or on a film of purified [ 3H] proline - labeled type IV collagen.	Cells,0,5,Cell	lung,31,35,Organ	13762NF cell line,86,103,Cell	all - trans - RA,156,172,Chemical	extracellular matrix,223,243,Cellular_component	rat,266,269,Organism	lung endothelial cells,270,292,Cell	type IV collagen,342,358,Gene_or_gene_product	"[{""token"": ""Cells"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Cell""}, {""token"": ""lung"", ""start_span"": 31, ""end_span"": 35, ""type"": ""Organ""}, {""token"": ""13762NF cell line"", ""start_span"": 86, ""end_span"": 103, ""type"": ""Cell""}, {""token"": ""all - trans - RA"", ""start_span"": 156, ""end_span"": 172, ""type"": ""Chemical""}, {""token"": ""extracellular matrix"", ""start_span"": 223, ""end_span"": 243, ""type"": ""Cellular_component""}, {""token"": ""rat"", ""start_span"": 266, ""end_span"": 269, ""type"": ""Organism""}, {""token"": ""lung endothelial cells"", ""start_span"": 270, ""end_span"": 292, ""type"": ""Cell""}, {""token"": ""type IV collagen"", ""start_span"": 342, ""end_span"": 358, ""type"": ""Gene_or_gene_product""}]"	test
In examining the metabolic basis for selenoperoxidase - dependent resistance, we found that glucose - replete Se ( -) cells reduce t - BuOOH to t - butanol far more slowly than Se ( +) cells, the ratio of the first - order rate constants approximating that of the GPX activities ( L1210 cells) or PHGPX activities ( K562 cells).	selenoperoxidase,37,53,Gene_or_gene_product	glucose,92,99,Chemical	t - BuOOH,131,140,Chemical	t - butanol,144,155,Chemical	GPX,264,267,Gene_or_gene_product	L1210 cells,281,292,Cell	PHGPX,297,302,Gene_or_gene_product	K562 cells,316,326,Cell	"[{""token"": ""selenoperoxidase"", ""start_span"": 37, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""glucose"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Chemical""}, {""token"": ""t - BuOOH"", ""start_span"": 131, ""end_span"": 140, ""type"": ""Chemical""}, {""token"": ""t - butanol"", ""start_span"": 144, ""end_span"": 155, ""type"": ""Chemical""}, {""token"": ""GPX"", ""start_span"": 264, ""end_span"": 267, ""type"": ""Gene_or_gene_product""}, {""token"": ""L1210 cells"", ""start_span"": 281, ""end_span"": 292, ""type"": ""Cell""}, {""token"": ""PHGPX"", ""start_span"": 297, ""end_span"": 302, ""type"": ""Gene_or_gene_product""}, {""token"": ""K562 cells"", ""start_span"": 316, ""end_span"": 326, ""type"": ""Cell""}]"	test
Interestingly, crossing of cyclin D1 transgenic mice with E mu L - myc transgenics that express their transgene in both B - and T - cells but predominantly develop T - cell tumours leads in double transgenics exclusively to B - cell neoplasia.	cyclin D1,27,36,Gene_or_gene_product	E mu,58,62,Gene_or_gene_product	L - myc,63,70,Gene_or_gene_product	B -,120,123,Cell	T - cells,128,137,Cell	T - cell tumours,164,180,Cancer	transgenics,197,208,Organism	B - cell neoplasia,224,242,Cell	"[{""token"": ""cyclin D1"", ""start_span"": 27, ""end_span"": 36, ""type"": ""Gene_or_gene_product""}, {""token"": ""E mu"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""L - myc"", ""start_span"": 63, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""B -"", ""start_span"": 120, ""end_span"": 123, ""type"": ""Cell""}, {""token"": ""T - cells"", ""start_span"": 128, ""end_span"": 137, ""type"": ""Cell""}, {""token"": ""T - cell tumours"", ""start_span"": 164, ""end_span"": 180, ""type"": ""Cancer""}, {""token"": ""transgenics"", ""start_span"": 197, ""end_span"": 208, ""type"": ""Organism""}, {""token"": ""B - cell neoplasia"", ""start_span"": 224, ""end_span"": 242, ""type"": ""Cell""}]"	test
Little difference was observed in their transforming efficiency ( 0. 2 - 0. 3 transformants / micrograms DNA) between the combinations of oncogenes applied but a tendency was noted that cells transfected with ras or src in combination with myc developed the capacity to grow for a longer period and differentiated at a later stage than those transfected solely with ras or src.	transformants,78,91,Cell	DNA,105,108,Cellular_component	cells,186,191,Cell	ras,209,212,Gene_or_gene_product	src,216,219,Gene_or_gene_product	myc,240,243,Gene_or_gene_product	ras,366,369,Gene_or_gene_product	src,373,376,Gene_or_gene_product	"[{""token"": ""transformants"", ""start_span"": 78, ""end_span"": 91, ""type"": ""Cell""}, {""token"": ""DNA"", ""start_span"": 105, ""end_span"": 108, ""type"": ""Cellular_component""}, {""token"": ""cells"", ""start_span"": 186, ""end_span"": 191, ""type"": ""Cell""}, {""token"": ""ras"", ""start_span"": 209, ""end_span"": 212, ""type"": ""Gene_or_gene_product""}, {""token"": ""src"", ""start_span"": 216, ""end_span"": 219, ""type"": ""Gene_or_gene_product""}, {""token"": ""myc"", ""start_span"": 240, ""end_span"": 243, ""type"": ""Gene_or_gene_product""}, {""token"": ""ras"", ""start_span"": 366, ""end_span"": 369, ""type"": ""Gene_or_gene_product""}, {""token"": ""src"", ""start_span"": 373, ""end_span"": 376, ""type"": ""Gene_or_gene_product""}]"	test
By introducing a cDNA library derived from rat embryonic fibroblast cells, we isolated several morphologically flat revertants of rat 3Y1 cells transformed by the E6 and E7 genes of human papillomavirus type 18 ( HPV18).	rat,43,46,Organism	embryonic fibroblast cells,47,73,Cell	rat,130,133,Organism	3Y1 cells,134,143,Cell	E6,163,165,Gene_or_gene_product	E7,170,172,Gene_or_gene_product	human papillomavirus type 18,182,210,Organism	HPV18,213,218,Organism	"[{""token"": ""rat"", ""start_span"": 43, ""end_span"": 46, ""type"": ""Organism""}, {""token"": ""embryonic fibroblast cells"", ""start_span"": 47, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""rat"", ""start_span"": 130, ""end_span"": 133, ""type"": ""Organism""}, {""token"": ""3Y1 cells"", ""start_span"": 134, ""end_span"": 143, ""type"": ""Cell""}, {""token"": ""E6"", ""start_span"": 163, ""end_span"": 165, ""type"": ""Gene_or_gene_product""}, {""token"": ""E7"", ""start_span"": 170, ""end_span"": 172, ""type"": ""Gene_or_gene_product""}, {""token"": ""human papillomavirus type 18"", ""start_span"": 182, ""end_span"": 210, ""type"": ""Organism""}, {""token"": ""HPV18"", ""start_span"": 213, ""end_span"": 218, ""type"": ""Organism""}]"	test
